<SEC-DOCUMENT>0001013762-24-002108.txt : 20240729
<SEC-HEADER>0001013762-24-002108.hdr.sgml : 20240729
<ACCEPTANCE-DATETIME>20240729163051
ACCESSION NUMBER:		0001013762-24-002108
CONFORMED SUBMISSION TYPE:	S-1
PUBLIC DOCUMENT COUNT:		19
FILED AS OF DATE:		20240729
DATE AS OF CHANGE:		20240729

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ACTELIS NETWORKS INC
		CENTRAL INDEX KEY:			0001141284
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMUNICATIONS EQUIPMENT, NEC [3669]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				522160309
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-281079
		FILM NUMBER:		241152839

	BUSINESS ADDRESS:	
		STREET 1:		4039 CLIPPER COURT
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538
		BUSINESS PHONE:		510-545-1040

	MAIL ADDRESS:	
		STREET 1:		4039 CLIPPER COURT
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1
<SEQUENCE>1
<FILENAME>ea0210134-s1_actelis.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Jul 29 19:49:55 UTC 2024 -->
<html xmlns:asns="http://www.actelis.com/20240331" xmlns:compsci="http://compsciresources.com" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml">
<head>
     <title> </title>

<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
filed with the United States Securities and Exchange Commission on July 29, 2024.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registration
No. 333-</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNITED
STATES<br/>
SECURITIES AND EXCHANGE COMMISSION<br/>
Washington, D.C. 20549</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<b><br/>
FORM <ix:nonNumeric contextRef="c0" name="dei:DocumentType" id="ixv-3642">S-1</ix:nonNumeric><br/>
REGISTRATION STATEMENT<br/>
UNDER<br/>
THE SECURITIES ACT OF 1933</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-39"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Actelis
Networks, Inc.</b></span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Exact
Name of Registrant as Specified in Its Charter)</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; width: 34%; border-bottom: black 1.5pt solid; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="ixv-53"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Delaware</b></span></ix:nonNumeric></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3669</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>52-2160309</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(State or Other Jurisdiction of<br/> Incorporation or Organization)</i></span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Primary Standard Industrial <br/> Classification Code Number)</i></span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(I.R.S.&#160;Employer<br/> Identification Number)</i></span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Actelis
Networks, Inc.<br/>
4039 Clipper Court<br/>
Fremont, CA 94538<br/>
(510)&#160;545-1045</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Address,
Including Zip Code, and Telephone Number, Including Area Code, of Registrant&#8217;s Principal Executive Offices)</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tuvia
Barlev<br/>
Chief Executive Officer and Chairman of the Board of Directors<br/>
Actelis Networks, Inc.<br/>
4039 Clipper Court<br/>
Fremont, CA 94538<br/>
(510)&#160;545-1045<br/>
</b><i>(Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent For Service)</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Copies
to:</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Eyal
Peled, Esq.<br/>
Greenberg Traurig LLP<br/>
One Vanderbilt Avenue,<br/>
New York, New York 10017<br/>
Phone: (212) 801-9210<br/>
Fax: (212) 801-6400</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Approximate
date of commencement of proposed sale to the public: </b>As soon as practicable after the effective date of this registration statement.</span></p><div>

</div><p style="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule&#160;415 under
the Securities Act&#160;of&#160;1933 check the following box. &#9746;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is filed to register additional securities for an offering pursuant to Rule&#160;462(b)&#160;under the Securities Act, please
check the following box and list the Securities Act registration statement number of the earlier effective registration statement for
the same offering. &#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule&#160;462(c)&#160;under the Securities Act, check the following box and
list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule&#160;462(d)&#160;under the Securities Act, check the following box and
list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company,
or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller
reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange&#160;Act.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large&#160;accelerated&#160;filer</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated&#160;filer</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt"><ix:nonNumeric contextRef="c0" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="ixv-180"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated&#160;filer</span></ix:nonNumeric></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller&#160;reporting&#160;company</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntitySmallBusiness" id="ixv-187"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></ix:nonNumeric></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging&#160;growth&#160;company</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntityEmergingGrowthCompany" id="ixv-197"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></ix:nonNumeric></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section&#160;7(a)(2)(B)&#160;of the Securities Act. <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityExTransitionPeriod" id="ixv-3643">&#9744;</ix:nonNumeric></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the
Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective
in accordance with Section&#160;8(a)&#160;of the Securities Act&#160;of&#160;1933, as amended, or until the Registration Statement shall
become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section&#160;8(a), may determine.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>


</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="color: Red">&#160;</span></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>The
information in this preliminary prospectus is not complete and may be changed. We may not sell these securities until the registration
statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities
and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>PRELIMINARY
    PROSPECTUS</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 69%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>SUBJECT
    TO COMPLETION DATED JULY 29, 2024</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img alt="" src="image_001.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Actelis
Networks, Inc.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2,069,317
Shares of Common Stock </b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus relates to the resale, from time to time, by the selling stockholders identified in this prospectus, or the selling stockholders,
of up to 2,069,317 shares of our common stock, par value $0.0001 per share, issuable upon the exercise of warrants, as further described
below under &#8220;Prospectus Summary &#8212; Recent Developments &#8212; July 2024 Warrant Inducement.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not selling any common stock under this prospectus and will not receive any of the proceeds from the sale or other disposition of
shares by any of the selling stockholders, however, we will receive proceeds from the exercise of any Warrants for cash.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
selling stockholders or its transferees, pledgees, assignees, or successors-in-interest may offer and sell or otherwise dispose of the
shares of common stock described in this prospectus from time to time through public or private transactions at prevailing market prices,
at prices related to prevailing market prices or at privately negotiated prices. The selling stockholder will bear all commissions and
discounts, if any, attributable to the sales of shares. We will bear all other costs, expenses, and fees in connection with the registration
of the shares. See &#8220;Plan of Distribution&#8221; beginning on page 15 for more information about how a selling stockholder may sell
or dispose of the shares of Common Stock.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is traded on the Nasdaq Capital Market under the symbol &#8220;ASNS.&#8221; On July 26, 2024, the closing price of our common
stock on the Nasdaq Capital Market was $1.58 per share.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investing
in our securities involves a high degree of risk. You should read this prospectus supplement and the accompanying prospectus as well
as the information incorporated herein and therein by reference carefully before you make your investment decision. See &#8220;Risk Factors&#8221;
beginning on page 5 of this prospectus.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined
if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
date of this prospectus is &#160;&#160;&#160;, 2024.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF CONTENTS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#a_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">About this Prospectus</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#a_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cautionary Note Regarding Forward-Looking Statements</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#a_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prospectus Summary</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><a href="#a_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk Factors</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><a href="#a_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of Proceeds</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><a href="#a_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling Stockholders</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><a href="#a_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description of Offered Securities</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><a href="#a_008"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plan of Distribution</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><a href="#a_009"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal Matters</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><a href="#a_010"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Experts</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><a href="#a_011"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where You Can Find More Information</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><a href="#a_012"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporation by Reference</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ABOUT
THIS PROSPECTUS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus is part of a registration statement that we filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;). The
selling stockholders named in this prospectus may from time to time sell the securities described in the prospectus. You should read
this prospectus together with the more detailed information regarding our company, our Common stock, and our financial statements and
notes to those statements that appear elsewhere in this prospectus and any applicable prospectus supplement together with the additional
information that we incorporate in this prospectus by reference, which we describe under the heading &#8220;Where You Can Find More Information.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should rely only on the information contained in, or incorporated by reference in, this prospectus and in any accompanying prospectus
supplement. We have not authorized anyone to provide you with different information from that contained in, or incorporated by reference
in, this prospectus. You should not assume that the information in this prospectus or any prospectus supplement is accurate as of any
date other than the date on the front of those documents or that any document incorporated by reference is accurate as of any date other
than its filing date. You should not consider this prospectus to be an offer or solicitation relating to the securities in any jurisdiction
in which such an offer or solicitation relating to the securities is not authorized. Furthermore, you should not consider this prospectus
to be an offer or solicitation relating to the securities if the person making the offer or solicitation is not qualified to do so, or
if it is unlawful for you to receive such an offer or solicitation.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
this prospectus, we frequently use the terms &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; &#8220;our company,&#8221; and the
&#8220;Company&#8221; to refer to Actelis Networks, Inc.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 4; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus and the documents incorporated by reference herein contain certain &#8220;forward-looking statements&#8221; within the meaning
of the Private Securities Litigation Reform Act&#160;of&#160;1995, Section&#160;27A of the Securities Act&#160;of&#160;1933, as amended
(the &#8220;Securities Act&#8221;), and Section&#160;21E of the Securities Exchange&#160;Act&#160;of&#160;1934, as amended (the Exchange&#160;Act&#8221;).
We have tried, whenever possible, to identify these forward-looking statements using words such as &#8220;may,&#8221; &#8220;will,&#8221;
&#8220;expect,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;continue,&#8221;
&#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;seek,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;potential,&#8221;
&#8220;ongoing,&#8221; and similar expressions to identify forward-looking statements, whether in the negative or the affirmative. These
statements reflect our current beliefs and are based on information currently available to us. Accordingly, such forward-looking statements
involve known and unknown risks, uncertainties and other factors which could cause our actual results, performance or achievements to
differ materially from those expressed in, or implied by, such statements. Forward-looking statements contained herein include, but are
not limited to, statements about:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    history of losses and need for additional capital to fund our operations and our ability to obtain additional capital on acceptable
    terms, or at all;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to protect our intellectual property and continue to innovate;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    success in retaining or recruiting, or changes required in, our officers, key employees or directors;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    potential insufficiency of our disclosure controls and procedures to detect errors or acts of fraud;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    accuracy of our estimates regarding expenses, future revenues, and capital requirements;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    success of competing products or technologies that are or may become available;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to grow the business due to the uncertainty resulting from the COVID-19 pandemic or any future pandemic;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to comply with complex and increasing regulations by governmental authorities;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to regain and maintain compliance with continued listing requirements of the Nasdaq Capital Market;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to continue as a going concern;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">statements
    as to the impact of the political and security situations in Israel on our business, including due to the number of armed conflicts
    between Israel and Hamas (an Islamist militia and political group in the Gaza Strip) and Hezbollah (an Islamist militia and political
    group in Lebanon);</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    public securities&#8217; potential liquidity and trading; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    expectations regarding the period during which we qualify as an emerging growth company under the JOBS Act.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements are based on our management&#8217;s current expectations, estimates, forecasts and projections about our business and the
industry in which we operate and our management&#8217;s beliefs and assumptions, and are not guarantees of future performance or development
and involve known and unknown risks, uncertainties and other factors that are in some cases beyond our control. As a result, any or all
of our forward-looking statements herein may turn out to be inaccurate. Important factors that may cause actual results to differ materially
from current expectations include, among other things, those listed under &#8220;Risk Factors,&#8221; Use of Discussion and Analysis
of Financial Condition and Results of Operations,&#8221; &#8220;Business&#8221; and elsewhere herein or by incorporation by reference.
Potential investors are urged to consider these factors carefully in evaluating the forward-looking statements. You should read thoroughly
this prospectus and the documents that we refer to with the understanding that our actual future results may be materially different
from and worse than what we expect. We qualify all of our forward-looking statements by these cautionary statements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
forward-looking statements included in this prospectus speak only as of the date of this prospectus. Although we believe that the expectations
reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance
and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we
assume no obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in
the future. You should, however, review the factors and risks we describe in the reports we will file from time to time with the SEC
after the date of this prospectus. See &#8220;Where You Can Find More Information.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 19, 2023, we effected a reverse stock split of our shares of common stock at the ratio of 1-for-10. Unless indicated otherwise
by the context, all common stock, option, warrant and per share amounts, as well as share prices appearing in this prospectus have been
adjusted to give retroactive effect to the stock split for all periods presented.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 5; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><div style="padding: 5pt; border: Black 1.5pt solid">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<a id="a_003"></a><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROSPECTUS
SUMMARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>This
summary highlights information contained elsewhere in this prospectus. Because this is only a summary, it does not contain all of the
information that may be important to you. You should read this entire prospectus and should consider, among other things, the matters
set forth under &#8220;Risk Factors,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;
and our consolidated financial statements and related notes thereto appearing elsewhere in this prospectus before making your investment
decision. This prospectus contains forward-looking statements and information relating to Actelis Networks, Inc. See &#8220;Cautionary
Note Regarding Forward-Looking Statements&#8221; on page iii</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Actelis
Networks, Inc. (&#8220;we&#8221;, &#8220;the Company&#8221;, &#8220;Actelis&#8221;, &#8220;us&#8221;, &#8220;our&#8221;) is a market
leader in cyber-hardened, rapid-deployment networking solutions for wide-area IoT applications including federal, state and local government,
intelligent traffic systems (&#8220;ITS&#8221;), military, utility, rail, telecom and campus applications. Our unique portfolio of hybrid
fiber, environmentally hardened aggregation switches, high density Ethernet devices, advanced management software and cyber-protection
capabilities, unlocks the hidden value of essential networks, delivering safer connectivity for rapid, cost-effective deployment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
networking solutions use a combination of newly deployed fiber infrastructure and existing copper and coaxial lines which our patented
technology can upgrade to Fiber-grade to jointly create what we believe to be a highly cost-effective, secure, and quick-to-deploy network.
Our patent protected hybrid fiber networking solutions deliver excellent communication over fiber to locations that may be easy to reach
with new fiber. However, for locations that are difficult, or too costly to reach with fiber, we can upgrade existing copper lines to
deliver cyber-hardened, high-speed connectivity without needing to replace the existing copper infrastructure with new fiber. We believe
that such hybrid fiber copper networking solution has distinct advantages in most real-life installations, while providing significant
budget savings and accelerating deployment of modern IoT networks, as based on our experience, most IoT&#160;projects have challenging,
hard to reach with fiber locations which may explode such projects&#8217; timeline and budgets. We believe that our solutions can provide
connectivity over either fiber or copper with speeds of up to multi-Gigabit communication, while supporting Fiber-grade reliability and
quality.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
primary focus of ours is to provide our customers with a cyber-secure network solution. We currently offer Triple-Shield protection of
data delivered with coding, scrambling and encryption of the network traffic. We also provide secure, encrypted access to our network
management software, and are working to further enhance system-level and device-level software protection. We are also working to introduce
additional capabilities for network-wide cyber protection software as an additional SW and license-based services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
high speed, long reach, reliable and secure connectivity is required, network operators usually resort to using wireline communication
over physical communication lines such as fiber, coax, and copper, rather than wireless communication that is more limited in performance,
reliability, reach and security. However, new fiber wireline infrastructure is costly to deploy, involves lengthy civil works to install,
and, based on our internal calculations, often accounts for more than 50% of total cost of ownership (ToC) and time to deploy wide-area
IoT projects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Providing
new fiber connectivity to hard-to-reach locations is especially costly and time-consuming, often requiring permits for boring, trenching,
and right-of-way, sometimes done over many miles. Connecting such hard-to-reach locations may cause significant delays and budget overruns
in IoT projects. Our solutions aim to solve these challenges by instantly enhancing performance of such existing copper and coax infrastructure
to fiber-grade performance, through the use of advanced signal processing and unique, patented network architecture, without the need
to run new fiber to hard-to-reach locations; thus, effectively accelerating deployment of many IoT projects, as we estimate, sometimes
from many&#160;months to only&#160;days. The result for the network owner is a hybrid network that optimizes the use of both new Fiber
(where available) as well as upgraded, fiber-grade copper and coax that is now modernized, digitized and cyber-hardened. This unique
hybrid network approach is making IoT projects often significantly more affordable, fast to deploy and predictable to plan and budget.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><div style="padding: 5pt; border: Black 1.5pt solid">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our solutions can also provide power over existing copper and coax lines to remotely power up network elements and IoT components
connected to them (like cameras, small cell and Wi-Fi base stations sensors etc.). Connecting power lines to millions of IoT locations
can be costly and very time consuming as well (similar to data connectivity, for the same reason&#160;&#8212;&#160;need for civil works).
By offering the ability to combine power delivery over the same existing copper and coax lines that we use for high-speed data, we believe
our solutions are solving yet another important challenge in connecting hard-to-reach locations. We believe that combining communication
and power over the same existing lines is particularly important to help connect many fifth generation, or 5G, small cells and Wi-Fi
base stations, as high cost of connectivity and power is often slowing their deployment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
our inception, our business has been focused on serving telecommunication service providers, also known as Telcos, to provide connectivity
for enterprises and residential customers. Our products and solutions have been deployed with more than 100 telecommunication service
providers worldwide, in enterprise, residential and mobile base station connectivity applications. In recent&#160;years, as we have further
developed our technology and introduced additional products, we turned our focus on serving the wide-area IoT markets. Our operations
are focused on our fast-growing IoT business, while maintaining our commitment to our existing Telco customers. In 2023, we introduced
new product offerings, some of which could serve both the IoT markets and our Telco customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent
Developments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>June
2024 Warrant Inducement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 5, 2024, we entered into an inducement agreement with a certain holder of certain of our existing warrants to purchase up to an
aggregate of 999,670 shares of our common stock originally issued on May 8, 2023, with a five and one-half year term, at an exercise
price of $2.75 per share (the &#8220;May 2023 Warrants&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the inducement agreement, the holder agreed to exercise for cash its May 2023 Warrants to purchase an aggregate of 999,670 shares
of our common stock at an exercise price of $2.75 per share, in consideration of our agreement to issue new common stock purchase warrants
(the &#8220;June 2024 Warrants&#8221;), as described below, to purchase up to an aggregate of 1,999,340 shares of our common stock, at
an exercise price of $2.00 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.C.
Wainwright &amp; Co., LLC (the &#8220;Placement Agent&#8221;) acted as our exclusive placement agent in connection with the June 2024
Warrant Inducement. In connection with the June 2024 Warrant Inducement, we issued to certain designees of the Placement Agent warrants
(the &#8220;June 2024 Placement Agent Warrants&#8221;) to purchase up to 69,977 shares of common stock (representing 7.0% of the Existing
Warrants being exercised), which have the same terms as the June 2024 Warrants, except that the Placement Agent Warrants have an exercise
price equal to $3.4375 per share (125% of the exercise price of the May 2023 Warrants). The June 2024 Warrants were immediately exercisable
from the date of issuance, until five and one-half year anniversary of such date for 999,670 of the June 2024 Warrants, and until twenty
four months anniversary of such date for the remaining 999,670 of the June 2024 Warrants. The Placement Agent Warrants are immediately
exercisable from the date of issuance, until the five and one-half year anniversary of such date. &#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
closing of the June 2024 Warrant Inducement occurred on June 6, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>July
2024 Warrant Inducement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 30, 2024, we entered into an inducement letter with a holder of our June 2024 Warrants, to purchase up to an aggregate of 999,670
shares of the June 2024 Warrants, originally issued on June 6, 2024, <span>with a twenty-four month term,
at an exercise price of $2.00 per share</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Pursuant
to the inducement letter, the holder agreed to exercise for cash its warrants to purchase an aggregate of 999,670 shares of our common
stock at an exercise price of $2.00 per share, in consideration of our agreement to issue new common stock purchase warrants (the &#8220;July
2024 Warrants&#8221;), as descried below, to purchase up to an aggregate of 1,999,340 shares of our common stock</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(the
&#8220;July 2024 Warrant Shares&#8221;)<span>, at an exercise price of $1.75 per share.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "></p><div>

</div><!-- Field: Page; Sequence: 7; Options: NewSection; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><div style="padding: 5pt; border: Black 1.5pt solid">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">We
engaged the Placement Agent to act as our exclusive placement agent in connection with the July 2024 Warrant Inducement. In connection
with the July 2024 Warrant Inducement, we </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">issued to
certain designees of the Placement Agent warrants (the &#8220;July 2024 Placement Agent Warrants&#8221;) to purchase up to 69,977 shares
of common stock (representing 7.0% of the Existing Warrants being exercised), which have the same terms as the July 2024 Warrants, except
that the Placement Agent Warrants have an exercise price equal to $2.50 per share (125% of the exercise price of the June 2024 Warrants).
The July 2024 Warrants were immediately exercisable from the date of issuance, until twenty four months anniversary of such date. The
July 2024 Placement Agent Warrants are immediately exercisable from the date of issuance, until the five and one-half year anniversary
of such date. &#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The closing of the July 2024 Warrant Inducement occurred on July 2,
2024. We also agreed to file this registration statement, providing for the resale of the New Warrant Shares issued or issuable upon the
exercise of the New Warrants (the &#8220;Resale Registration Statement&#8221;) as soon as practicable after the Closing Date (and in any
event within thirty (30) calendar days of the date of the Inducement Letter), and to use commercially reasonable efforts to have such
Resale Registration Statement declared effective by the SEC within sixty (60) calendar days following the date of the Inducement Letter
(or within ninety (90) calendar days following the date of the Inducement Letter in case of &#8220;full review&#8221; of the Resale Registration
Statement by the SEC) and to keep the Resale Registration Statement effective at all times until no holder of the July 2024 Warrants owns
any July 2024 Warrants or July 2024 Warrant Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nasdaq
Listing Compliance</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 25, 2023, we received a notification letter from the Listing Qualifications Staff (the &#8220;Staff&#8221;) of the Nasdaq Stock
Market LLC (&#8220;Nasdaq&#8221;) indicating that we are not in compliance with Nasdaq Listing Rule 5550(b)(1) due to our failure to
maintain a minimum of $2,500,000 in shareholders&#8217; equity (the &#8220;Minimum Shareholders&#8217; Equity Requirement&#8221;) or
any alternatives to such requirement. In order to maintain our listing on the Nasdaq Capital Market, we submitted a plan of compliance
addressing how we intended to regain compliance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2024, we received a&#160;delist&#160;determination letter from Nasdaq advising us that the Staff had determined to&#160;delist&#160;our
securities from Nasdaq due to non-compliance with the Minimum Shareholders&#8217; Equity Requirement, unless we timely request a hearing
before the Nasdaq Hearings Panel (the &#8220;Panel&#8221;). We timely requested a hearing before the Panel. On June 10, 2024, the Panel
granted our request for continued listing subject to us evidencing compliance with the Equity Rule by August 30, 2024. There can be no
assurance that we will be able to&#160;<span>timely demonstrate such&#160;</span>compliance with the
Equity Rule.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, on May 20, 2024, the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) notified the Company that it was not in compliance with
the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2), which requires the Company&#8217;s common stock to maintain
a minimum bid price of $1.00 per share. On June 20, 2024, the Company received a letter from Nasdaq that, for the 10 consecutive business
days from June 5, 2024 to June 28, 2024, the closing bid price of the Company&#8217;s common stock had been at $1.00 per share or greater.
Accordingly, the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) and Nasdaq considers the prior bid price deficiency
matter now closed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div><div>


</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><div style="padding: 5pt; border: Black 1.5pt solid">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
OFFERING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares
    of common stock currently outstanding</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 59%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,016,326
    shares of common stock.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
    offered by the selling stockholders</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up
    to 2,069,317 shares of the Company&#8217;s common stock, par value $0.0001 per share, consisting of: (i) 1,999,340 shares of our
    common stock issuable upon the exercise of the July 2024 Warrants, and (ii) 69,977 shares of our common stock issuable upon the exercise
    of the July 2024 Placement Agent Warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares
    of common stock to be outstanding assuming exercise of the warrants</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,085,643
    shares of common stock.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Selling
    Stockholders</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    of the shares of our common stock are being offered by the selling stockholders. See &#8220;Selling Stockholder&#8221; on page 7
    of this prospectus for more information on the selling stockholders.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Plan
    of Distribution</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    selling stockholders will determine when and how they will sell the common stock covered by this prospectus. See the &#8220;Plan
    of Distribution&#8221; section of this prospectus.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use
    of Proceeds</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    will not receive any proceeds from the sale of the Common Stock by the selling stockholders. All net proceeds from the sale of the
    Common Stock covered by this prospectus will go to the selling stockholders. However, we may receive the proceeds from any exercise
    of warrants if the selling stockholders do not exercise their warrants on a cashless basis, if and when exercised. See the section
    of this prospectus titled &#8220;Use of Proceeds.&#8221;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk
    Factors </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
    &#8220;Risk Factors&#8221; and other information appearing elsewhere in this prospectus for a discussion of factors you should carefully
    consider before deciding whether to invest in our securities.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Listings</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    common stock is listed on the Nasdaq Capital Market under the symbol &#8220;ASNS&#8221;.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated, all information in this prospectus (i) assumes no exercise of the outstanding warrants described above, and (ii)
gives retroactive effect to the 1-for-10 reverse stock split effected on April 19, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate
Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
were incorporated in Delaware in 1998. We completed our initial public offering on May 17, 2022 and our common stock is currently listed
on the Nasdaq Global Select Market under the symbol &#8220;ASNS.&#8221; Our principal executive offices are located at 4039 Clipper Court,
Fremont, CA 94538, and our telephone number is (510)-545-1040. The information contained on our website and available through our website
is not incorporated by reference into and should not be considered a part of this prospectus, and the reference to our website in this
prospectus is an inactive textual reference only.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 9; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RISK
FACTORS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
investment in our securities involves a high degree of risk. You should carefully consider the risk factors set forth in our most recent
Annual Report on Form 10-K on file with the SEC, which is incorporated by reference into this prospectus, as well as the following risk
factors, which supplement or augment the risk factors set forth in our Annual Report on Form 10-K. Before making an investment decision,
you should carefully consider these risks as well as other information we include or incorporate by reference in this prospectus. The
risks and uncertainties not presently known to us or that we currently deem immaterial may also materially harm our business, operating
results and financial condition and could result in a complete loss of your investment.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sales
of substantial amounts of our Common Stock by a selling stockholder, or the perception that these sales could occur, could adversely
affect the price of our Common Stock.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
sale by the selling stockholders of a significant number of shares of Common Stock could have a material adverse effect on the market
price of our Common Stock. In addition, the perception in the public markets that the selling stockholder may sell all or a portion of
its shares as a result of the registration of such shares for resale pursuant to this prospectus could also in and of itself have a material
adverse effect on the market price of our Common Stock. We cannot predict the effect, if any, that market sales of those shares of Common
Stock or the availability of those shares of Common Stock for sale will have on the market price of our Common Stock.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 10; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>USE
OF PROCEEDS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not selling any Common Stock under this Prospectus and we will not receive any proceeds from the sale of the Common Stock by the
selling stockholders. All net proceeds from the sale of the Common Stock covered by this prospectus will go to the selling stockholders.
We expect that the selling stockholders will sell their Common Stock as described under &#8220;Plan of Distribution.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may receive proceeds from the exercise of the warrants to the extent that these warrants are exercised for cash by the selling stockholders.
Warrants, however, are exercisable on a cashless basis under certain circumstances. If all of the warrants mentioned above were exercised
for cash in full, the gross proceeds would be approximately $3.7 million. We intend to use the net proceeds of such warrant exercise,
if any, for general corporate purposes. Pending such uses, we intend to invest the net proceeds in bank deposits. We can make no assurances
that any of the warrants will be exercised, or if exercised, that they will be exercised for cash, the quantity which will be exercised
or in the period in which they will be exercised.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 11; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SELLING
STOCKHOLDERS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of common stock being offered by the selling stockholders are those shares of common stock issuable upon exercise of the July
2024 Warrants and July 2024 Placement Agent Warrants previously issued in connection with the Warrant Inducement. For additional information
regarding the issuance of those shares of common stock and warrants, see &#8220;Prospectus Summary &#8212; Recent Developments &#8212;
Warrant Inducement&#8221; above. We are registering the shares of common stock in order to permit the selling stockholders to offer the
shares of common stock for resale from time to time. Other than with respect to the Placement Agent, which acted as our placement agent
in the July 2024 Warrant Inducement, the June 2024 Warrant Inducement, and in each of our December 2023 and May 2023 financings, except
for the ownership of the warrants issued to the Placement Agent, and the shares of common stock issued and issuable pursuant to prior
financings, the selling stockholders have not had any material relationship with us within the past three years.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below lists the selling stockholders and other information regarding the beneficial ownership of the shares of common stock by
each of the selling stockholders. The second column lists the number the shares of common stock beneficially owned by each selling stockholder,
based on its ownership of the shares of common stock, including shares underlying the July 2024 Warrants or Placement Agent Warrants,
as of July 20, 2024, assuming exercise of the July 2024 Warrants or the July 2024 Placement Agent Warrants held by the selling stockholders
on that date, without regard to any limitations on conversions or exercises. The third column lists the maximum number of the shares
of common stock being offered in this prospectus by the selling stockholders. The fourth and fifth columns list the amount of the shares
of common stock owned after the offering, by number of the shares of common stock and percentage of outstanding the shares of common
stock (assuming for the purpose of such percentage, 6,016,326 shares outstanding as of July 20, 2024) assuming in both cases the sale
of all of the shares of common stock offered by the selling stockholders pursuant to this prospectus, and without regard to any limitations
on conversions or exercises.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the July 2024 Warrants and the July 2024 Placement Agent Warrants issued in the July 2024 Warrant Inducement, a selling
stockholder may not exercise the warrants to the extent such exercise would cause such selling stockholder, together with its affiliates,
to beneficially own a number of shares of common stock which would exceed 4.99% or 9.99%, as applicable, of our then outstanding shares
of common stock following such exercise, excluding for purposes of such determination shares of common stock not yet issuable upon exercise
of the warrants and placement agent warrants which have not been exercised. The number of shares does not reflect this limitation. The
selling stockholders may sell all, some or none of their shares of common stock or July 2024 Warrants or the July 2024 Placement Agent
Warrants in this offering. See &#8220;Plan of Distribution.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Name of selling stockholder</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of <br/> Shares of <br/> Common&#160;Stock<br/> Owned <br/> Prior to<br/> Offering</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Maximum <br/> Number of <br/> Shares of <br/> Common&#160;Stock<br/> to be Sold <br/> Pursuant<br/> to this<br/> Prospectus</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares Beneficially<br/> Owned After Offering</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Percentage</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Armistice Capital, LLC<sup>(1)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,542,197</td><td style="width: 1%; text-align: left"><sup>(2)</sup></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,999,340</td><td style="width: 1%; text-align: left"><sup>(3)</sup></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left"><sup>(4)</sup></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">&#160;&#160;&#160;*</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael Vasinkevich<sup>(5)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">189,208</td><td style="text-align: left"><sup>(6)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44,872</td><td style="text-align: left"><sup>(7)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">144,336</td><td style="text-align: left"><sup>(8)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Noam Rubinstein<sup>(5)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">92,946</td><td style="text-align: left"><sup>(9)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,043</td><td style="text-align: left"><sup>(10)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">70,903</td><td style="text-align: left"><sup>(11)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Craig Schwabe<sup>(5)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,956</td><td style="text-align: left"><sup>(12)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,362</td><td style="text-align: left"><sup>(13)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,597</td><td style="text-align: left"><sup>(14)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charles Worthman<sup>(5)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,951</td><td style="text-align: left"><sup>(15)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">700</td><td style="text-align: left"><sup>(16)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,251</td><td style="text-align: left"><sup>(17)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denotes
    less than 1%.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    securities are directly held by Armistice Capital Master Fund Ltd., a Cayman Islands exempted company (the &#8220;Master Fund&#8221;),and
    may be deemed to be beneficially owned by: (i)&#160;Armistice Capital, LLC (&#8220;Armistice Capital&#8221;), as the investment manager
    of the Master Fund; and (ii)&#160;Steven Boyd, as the Managing Member of Armistice Capital. The warrants are subject to a beneficial
    ownership limitation of 4.99%, which such limitation restricts the Selling Stockholder from exercising that portion of the warrants
    that would result in the Selling Stockholder and its affiliates owning, after exercise, a number of shares of common stock in excess
    of the beneficial ownership limitation. The address of Armistice Capital Master Fund Ltd. is c/o Armistice Capital, LLC, 510 Madison
    Avenue, 7<sup>th</sup> Floor, New&#160;York, NY&#160;10022.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></p><p style="margin: 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 12; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of (i)1,271,187 shares of common stock issuable upon the exercise of warrants issued in December 2023, (ii) 999,670 shares of common
    stock issuable upon the exercise of the June 2024 Warrants issued in connection with the June 2024 Warrant Inducement; and (iii)
    1,999,340 shares of common stock issuable upon exercise of the July 2024 Warrants issued in connection with the July 2024 Warrant
    Inducement. All of these warrants are subject to a beneficial ownership limitation of 4.99%, which such limitation restrict the Master
    Fund from exercising that portion of the warrants that would result in the Master Fund and its affiliates owning, after exercise,
    a number of shares of common stock in excess of the beneficial ownership limitation.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of 1,999,340 shares of common stock issuable upon the exercise of the July 2024 Warrants issued in connection with the July 2024
    Warrant Inducement. </span></td></tr>
</table><div>

</div><p style="margin: 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Does
    not include (i) 1,271,187 shares of common stock issuable upon the exercise of warrants issued in December 2023, and (ii) 999,670
    shares of common stock issuable upon the exercise of the June 2024 Warrants issued in connection with the June 2024 Warrant Inducement.&#160;All
    of these warrants are subject to a beneficial ownership limitation of 4.99%, which such limitation restrict the Master Fund from
    exercising that portion of the warrants that would result in the Master Fund and its affiliates owning, after exercise, a number
    of shares of common stock in excess of the beneficial ownership limitation. </span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    of the selling stockholders is affiliated with H.C. Wainwright &amp; Co., LLC, a registered broker dealer with a registered address
    of H.C. Wainwright &amp; Co., LLC, 430 Park Ave, 3rd Floor, New York, NY 10022, and has sole voting and dispositive power over the
    securities held. The number of shares beneficially owned prior to this offering consist of shares of common stock issuable upon exercise
    of placement agent warrants, which were received as compensation. The selling stockholder acquired the placement agent warrants in
    the ordinary course of business and, at the time the placement agent warrants were acquired, the selling stockholder had no agreement
    or understanding, directly or indirectly, with any person to distribute such securities.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of (i) 42,404 shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection with the May 2023 Private
    Placement, (ii) 57,060 shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection with the December
    2023 Private Placement, (iii) 44,872 shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection
    with the June&#160;&#160;2024 Warrant Inducement, and (iv) 44,872 shares of common stock issuable upon exercise of Placement Agent
    Warrants issued in connection with the July 2024 Warrant Inducement.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of 44,872 shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection with the July 2024 Warrant
    Inducement.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of (i) 42,404 shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection with the May 2023 Private
    Placement, (ii) 57,060 shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection with the December
    2023 Private Placement; and (iii) 44,872 shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection
    with the June 2024 Warrant Inducement.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of (i) 20,830 shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection with the May 2023 Private
    Placement, (ii) 28,030 shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection with the December
    2023 Private Placement, (iii) 22,043 shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection
    with the June 2024 Warrant Inducement, and (iv) 22,043 shares of common stock issuable upon exercise of Placement Agent Warrants
    issued in connection with the July 2024 Warrant Inducement.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></p><div>

</div><!-- Field: Page; Sequence: 13; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of 22,043 shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection with the July 2024 Warrant
    Inducement.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of (i) 20,830 shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection with the May 2023 Private
    Placement, (ii) 28,030 shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection with the December
    2023 Private Placement, and (iii) 22,043 shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection
    with the June 2024 Warrant Inducement.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of (i) 2,232 shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection with the May 2023 Private
    Placement, (ii) 3,003 shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection with the December
    2023 Private Placement, and (iii) 2,362 shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection
    with the June 2024 Warrant Inducement, and (iv) 2,362 shares of common stock issuable upon exercise of Placement Agent Warrants issued
    in connection with the July 2024 Warrant Inducement.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of 2,362 shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection with the July 2024 Warrant
    Inducement.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of (i) 2,232 shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection with the May 2023 Private
    Placement, (ii) 3,003 shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection with the December
    2023 Private Placement, and (iii) 2,362 shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection
    with the June 2024 Warrant Inducement.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of (i) 661 shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection with the May 2023 Private
    Placement, (ii) 890 shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection with the December
    2023 Private Placement, (iii) 700 shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection
    with the June 2024 Warrant Inducement, and (iv) 700 shares of common stock issuable upon exercise of Placement Agent Warrants issued
    in connection with the July 2024 Warrant Inducement</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of 700 shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection with the July 2024 Warrant
    Inducement.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(17)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of (i) 661 shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection with the May 2023 Private
    Placement, (ii) 890 shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection with the December
    2023 Private Placement, and (iv) 700 shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection
    with the June 2024 Warrant Inducement.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 14; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_007"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DESCRIPTION
OF OFFERED SECURITIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
following description is intended as a summary of our Charter and our Bylaws, each of which will become effective prior to the effectiveness
of the registration statement of which this prospectus forms a part, and which will be filed as exhibits to the registration statement
of which this prospectus forms a part, and to the applicable provisions of the DGCL. Because the following is only a summary, it does
not contain all of the information that may be important to you. For a complete description, you should refer to our Charter and Bylaws.</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
selling stockholders may, from time to time, sell, transfer, or otherwise dispose of any or all of their shares of common stock or interests
in shares of common stock on any stock exchange, market, or trading facility on which the shares are traded or in private transactions
at fixed prices, at prevailing market prices at the time of sale, at prices related to the prevailing market price, at varying prices
determined at the time of sale, or at negotiated prices. This prospectus provides you with a general description of the common stock
the selling stockholders may offer.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Authorized
Capital Stock</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Charter authorizes us to issue up to 42,803,774&#160;shares consisting of 30,000,000&#160;shares of common stock with a par value of
US$0.0001 per share, 2,803,774&#160;shares of non-voting&#160;common stock with a par value of US$0.0001 per share and 10,000,000&#160;shares
of preferred stock with a par value of US$0.0001 per share. As of July 24, 2024, there were 52 holders of record of our common stock.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Stock</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of our common stock have the following rights, preferences and privileges:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting
Rights</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
holder of common stock is entitled to one vote for each share of common stock held on all matters submitted to a vote of stockholders.
Any action at a meeting at which a quorum is present will be decided by a majority of the voting power present in person or represented
by proxy, except in the case of any election of directors, which will be decided by a plurality of votes cast. There is no cumulative
voting.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividend
Rights</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of our common stock are entitled to receive dividends when, as and if declared by our board of directors out of funds legally available
for payment, subject to the rights of holders, if any, of any class of stock having preference over the common stock. Any decision to
pay dividends on our common stock will be at the discretion of our board of directors. Our board of directors may or may not determine
to declare dividends in the future. See &#8220;Dividend Policy.&#8221; The board&#8217;s determination to issue dividends will depend
upon our profitability and financial condition any contractual restrictions, restrictions imposed by applicable law and the SEC, and
other factors that our board of directors deems relevant.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation
Rights</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a voluntary or involuntary liquidation, dissolution or winding up of the Company, the holders of our common stock will be
entitled to share ratably on the basis of the number of shares held in any of the assets available for distribution after we have paid
in full, or provided for payment of, all of our debts and after the holders of all outstanding series of any class of stock have preference
over the common stock, if any, have received their liquidation preferences in full.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 15; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
Rights and Preferences</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the closing of this offering, holders of our common stock will have no pre-emptive, conversion, subscription or other rights, and there
are no redemption or sinking fund provisions applicable to our common stock. The rights, preferences and privileges of the holders of
our common stock are subject to and may be adversely affected by the rights of the holders of shares of any series of our preferred stock
that we may designate in the future. Upon the closing of this offering, shares of our common stock are not convertible into shares of
any other class of capital stock, nor are they subject to any redemption or sinking fund provisions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fully
paid and nonassessable</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of our outstanding shares of common stock are, and the shares of common stock to be issued in this offering will be, fully paid and nonassessable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred
stock</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are authorized to issue up to 10,000,000&#160;shares of preferred stock. Our Charter authorizes the board to issue these shares in one
or more series, to determine the designations and the powers, preferences and relative, participating, optional or other special rights
and the qualifications, limitations and restrictions thereof, including the dividend rights, conversion or exchange rights, voting rights
(including the number of votes per share), redemption rights and terms, liquidation preferences, sinking fund provisions and the number
of shares constituting the series. Our board of directors could, without stockholder approval, issue preferred stock with voting and
other rights that could adversely affect the voting power and other rights of the holders of common stock and which could have the effect
of making it more difficult for a third party to acquire, or of discouraging a third party from attempting to acquire, a majority of
our outstanding voting stock. Upon the closing of this offering, no shares of preferred stock will be outstanding.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Charter
and Bylaw Provisions</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Charter
and Bylaw Provisions</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Charter and our Bylaws to be effective upon the closing of this offering, include a number of provisions that could deter hostile takeovers
or delay or prevent changes in control of our management team, including the following:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Board
    of Directors vacancies. </i>Our Charter to be effective upon the closing of this offering, provides that vacancies on the board of
    directors may be filled only by the affirmative vote of a majority of the directors then in office, irrespective of whether there
    is a quorum, or by a sole remaining director. Additionally, the number of directors to serve on our board of directors is fixed solely
    and exclusively by resolution duly adopted by our board of directors. This would prevent a stockholder from increasing the size of
    our board of directors and then gaining control of our board of directors by filling the resulting vacancies with its own nominees.
    This makes it more difficult to change the composition of our board of directors but promotes continuity of management.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Classified
    Board of Directors. </i>In accordance with our Charter, as it will be in effect following the effectiveness of the registration statement
    of which this prospectus forms a part, our board of directors will be divided into three classes with staggered three-year&#160;terms.
    At each annual general meeting of stockholders, the successors to directors whose terms then expire will be elected to serve from
    the time of election and qualification until the third annual meeting following election. Our directors will be divided among the
    three classes. We expect that any additional directorships resulting from an increase in the number of directors will be distributed
    among the three classes so that, as nearly as possible, each class will consist of one-third&#160;of the directors. The division
    of our board of directors into three classes with staggered three-year&#160;terms may delay or prevent a change of our management
    or a change in control.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Special
    Meetings of Stockholders. </i>Our Bylaws to be effective upon the closing of this offering, provides that special meetings of our
    stockholders may be called by the board of directors acting pursuant to a resolution approved by the affirmative vote of a majority
    of the directors then in office, and special meetings of stockholders may not be called by any other person or persons.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Page; Sequence: 16; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>No
    Cumulative Voting. </i>The DGCL provides that stockholders are not entitled to the right to cumulate votes in the election of directors
    unless the corporation&#8217;s certificate of incorporation provides otherwise. Our Charter does not provide for cumulative voting.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Amendment
    of Charter and Bylaw Provisions. </i>Any amendment of our Charter requires the affirmative vote of the majority of the outstanding
    shares of capital stock entitled to vote on such amendment, and the affirmative vote of the majority of the outstanding shares of
    each class entitled to vote thereon as a class, except that the provision in the Charter regarding the staggered board may not be
    repealed or amended without the vote of the holders of not less than 80% of the Company&#8217;s voting stock, voting as a single
    class. Amendments to our Bylaws may be executed pursuant to a resolution by the Board of Directors pursuant to an affirmative vote
    of a majority of the directors then in office, or by the affirmative vote of at least 75% of the outstanding shares of capital stock
    entitled to vote.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#9679;</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Delaware
    Business Combination Statute. </i>The Company is subject to the &#8220;business combination&#8221; provisions of Section&#160;203
    of the DGCL.&#160;In general, Section&#160;203 prohibits a publicly held Delaware corporation from engaging in a business combination
    with an interested stockholder for a period of three&#160;years following the date such person becomes an interested stockholder,
    unless the business combination or the transaction in which such person becomes an interested stockholder is approved in a prescribed
    manner. Generally, a &#8220;business combination&#8221; includes a merger, asset or stock sale, or other transaction resulting in
    a financial benefit to the interested stockholder. Generally, an &#8220;interested stockholder&#8221; is a person that, together
    with affiliates and associates, owns, or within three&#160;years prior to the determination of interested stockholder status did
    own, 15% or more of a corporation&#8217;s voting stock. The existence of this provision may have an anti-takeover effect with respect
    to transactions not approved in advance by our Board of Directors, and the anti-takeover effect includes discouraging attempts that
    might result in a premium over the market price for the shares of our common stock.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exclusive
    Forum. </i>Unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware
    is the sole and exclusive forum for (i)&#160;any derivative action or proceeding brought on our behalf, (ii)&#160;any action asserting
    a claim of breach of a fiduciary duty owed by any of our current or former directors, officers, stockholder or other employees to
    us or our stockholders, (iii)&#160;any action asserting a claim against the Corporation or any current or former director, officer,
    stockholder, employee or agent of the Corporation arising pursuant to any provision of the DGCL, our Charter or our Bylaws, (iv)&#160;any
    action to interpret, apply, enforce or determine the validity of the Company&#8217;s Charter or Bylaws, (v)&#160;any action asserting
    a claim against us governed by the internal affairs doctrine or (vi)&#160;any action asserting an &#8220;internal corporate claim&#8221;
    as that term is defined in Section&#160;115 of the General Corporation Law. The federal district courts of the United&#160;States
    of America shall be the exclusive forum for the resolution of any complaint, claim or proceeding asserting a cause of action arising
    under the Exchange&#160;Act or the Securities Act. Furthermore, Section&#160;22 of the Securities Act creates concurrent jurisdiction
    for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and
    regulations thereunder. Stockholders cannot waive compliance with the federal securities laws and the rules and regulations thereunder.
    Any person or entity purchasing or otherwise acquiring or holding any interest in shares of our capital stock shall be deemed to
    have notice of and consented to the forum provision in our Charter. This choice of forum provision may limit a stockholder&#8217;s
    ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees,
    which may discourage such lawsuits against us and our directors, officers and other employees.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Anti-Takeover&#160;Provisions</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provisions of the DGCL, our Charter and our Bylaws may have the effect of delaying, deferring or discouraging another person from acquiring
control of our company. These provisions, which are summarized below, may have the effect of discouraging takeover bids. They are also
designed, in part, to encourage persons seeking to acquire control of us to negotiate first with our board of directors. We believe that
the benefits of increased protection of our potential ability to negotiate with an unfriendly or unsolicited acquirer outweigh the disadvantages
of discouraging a proposal to acquire us because negotiation of these proposals could result in an improvement of their terms.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Charter established a classified board of directors, divided in three classes with staggered three-year&#160;terms. Under the classified
board of directors structure, only one class of directors would be elected at each annual meeting of our stockholders, with the other
classes continuing for the remainder for their respective three-year&#160;terms. Under the classified board of directors structure: (i)&#160;directors
in Class&#160;I, consisting of Gideon Marks, are to stand for election at the Annual Meeting to be held in 2026; (ii)&#160;directors
in Class&#160;II, consisting of Joseph Moscovitz, are to stand for election at the annual meeting of stockholders to be held in 2024;
and (iii)&#160;directors in Class&#160;III, consisting of Israel Niv and Tuvia Barlev, are to stand for election at the annual meeting
of stockholders to be held in 2025.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 17; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Limitations
on Liability, Indemnification of officers and directors and insurance</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Charter and Bylaws contain provisions that limit the liability of our directors for monetary damages to the fullest extent permitted
by the DGCL.&#160;Consequently, our directors will not be personally liable to us or our stockholders for monetary damages for any breach
of fiduciary duties as directors, except liability for:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    breach of the director&#8217;s duty of loyalty to us or our stockholders;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unlawful
    payments of dividends or unlawful stock repurchases, or redemptions as provided in Section&#160;174 of the DGCL; or</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    transaction from which the director derived an improper personal benefit.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Listing</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is listed on the Nasdaq Capital Market under the symbol &#8220;ASNS&#8221;.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transfer
Agent and Registrar</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transfer agent and registrar for our common stock will be VStock Transfer, LLC.&#160;The transfer agent and registrar&#8217;s address
is 18 Lafayette Place, Woodmere, NY&#160;11598.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exclusive
Forum</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Charter provides that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware
will be the sole and exclusive forum for any stockholder for (a)&#160;any derivative action or proceeding brought on our behalf, (b)&#160;any
action asserting a claim of breach of a fiduciary duty owed by, or other wrongdoing by, any current or former director, officer, stockholder,
employee or agent of the Company to the Company or the Company&#8217;s stockholders, (c)&#160;any action asserting a claim against the
Corporation or any current or former director, officer, stockholder, employee or agent of the Corporation arising pursuant to any provision
of the DGCL or the Company&#8217;s Certificate of Incorporation or Bylaws, (d)&#160;any action to interpret, apply, enforce or determine
the validity of the Company&#8217;s Certificate of Incorporation or Bylaws, or (e)&#160;any action asserting a claim governed by the
internal affairs doctrine or (f)&#160;any action asserting an &#8220;internal corporate claim&#8221; as that term is defined in Section&#160;115
of the General Corporation Law. The federal district courts of the United&#160;States of America shall be the exclusive forum for the
resolution of any complaint, claim or proceeding asserting a cause of action arising under the Exchange&#160;Act or the Securities Act.
Furthermore, Section&#160;22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought
to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
cannot waive compliance with the federal securities laws and the rules and regulations thereunder. Any person or entity purchasing or
otherwise acquiring or holding any interest in shares of our capital stock shall be deemed to have notice of and consented to the forum
provision in our Charter.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
choice-of-forum&#160;provision may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for
disputes with the Company or its directors, officers or other employees, and may result in increased costs to a stockholder who has to
bring a claim in a forum that is not convenient to the stockholder, which may discourage such lawsuits. Although under Section&#160;115
of the DGCL, exclusive forum provisions may be included in a company&#8217;s certificate of incorporation, the enforceability of similar
forum provisions in other companies&#8217; certificates or incorporation or bylaws has been challenged in legal proceedings, and it is
possible that a court could find these types of provisions to be inapplicable or unenforceable. If a court were to find the exclusive
forum provision of our Charter inapplicable or unenforceable with respect to one or more of the specified types of actions or proceedings,
we may incur additional costs associated with resolving such matters in other jurisdictions, which could materially and adversely affect
our business, financial condition and results of operations and result in a diversion of the time and resources of our management and
board of directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 18; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Anti-Takeover&#160;Provisions
of the DGCL and Charter Provisions</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
provisions of the DGCL and certain provisions included in our Charter and Bylaws summarized below may be deemed to have an anti-takeover&#160;effect
and may delay, deter, or prevent a tender offer or takeover attempt that a stockholder might consider to be in its best interests, including
attempts that might result in a premium being paid over the market price for the shares held by stockholders.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Removal
of Directors</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Bylaws provide that stockholders may only remove a director with or without cause by a vote of no less than a majority of the shares
present in person or by proxy at the meeting and entitled to vote, voting together as a single class.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Amendments
to Certificate of Incorporation</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
sections of our Certificate of Incorporation require the affirmative vote of the holders of a majority of the voting power of the then
outstanding shares of capital stock of the Company entitled to vote, voting together as a single class, except that the provision in
the Charter regarding the staggered board may not be repealed or amended without the vote of the holders of not less than 80% of the
Company&#8217;s voting stock, voting as a single class.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Staggered
Board</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
board of directors is divided into three classes, with regular three-year&#160;staggered terms. This classification system increases
the difficulty of replacing a majority of the directors and may tend to discourage a third-party&#160;from making a tender offer or otherwise
attempting to gain control of the Company. In addition, under Delaware law, the Certificate and the By-Laws, the Company&#8217;s directors
may be removed from office by the stockholders only for cause and only in the manner provided for in the Certificate. These factors may
maintain the incumbency of the board of directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Amendments
to Bylaws</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Charter limits the abilities of the directors and stockholders to amend our Bylaws in certain circumstances. In particular, the Bylaws
may be amended only by the vote of a majority of all of the directors then in office, or by the affirmative vote of the stockholders
holding at least 75% of the outstanding shares of capital stock entitled to vote in accordance with the provisions of the Charter, Bylaws,
and the DGCL.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>No
Cumulative Voting</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Charter does not provide for cumulative voting.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Special
Meetings of Stockholders</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Bylaws provide that, except as otherwise required by law, special meetings of the stockholders may be called only by an officer at the
request of a majority of our board of directors, by our Chief Executive Officer or President or by the holders of not less than 25% of
the holders of stock entitled to vote at the meeting.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stockholders
Agreement</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are party to the Amended and Restated Stockholders Agreement, dated February 2, 2016, or the Stockholders Agreement, pursuant to which
certain holders of our common stock have the right to demand that we file a registration statement or request that their common stock
be covered by a registration statement that we are otherwise filing. All rights under the Stockholders Agreement will terminate upon
the closing of this offering.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 19; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="a_008"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PLAN
OF DISTRIBUTION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
selling stockholders of the Shares and any of its pledgees, assignees and successors-in-interest may, from time to time, sell any or
all of their securities covered hereby on the Nasdaq Capital Market or any other stock exchange, market or trading facility on which
the securities are traded or in private transactions. These sales may be at fixed or negotiated prices. The selling stockholders may
use any one or more of the following methods when selling securities:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary
    brokerage transactions and transactions in which the broker-dealer solicits purchasers;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">block
    trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the block
    as principal to facilitate the transaction;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchases
    by a broker-dealer as principal and resale by the broker-dealer for its account;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    exchange distribution in accordance with the rules of the applicable exchange;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">privately
    negotiated transactions;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">settlement
    of short sales;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    transactions through broker-dealers that agree with the selling stockholder to sell a specified number of such securities at a stipulated
    price per security;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
    the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    combination of any such methods of sale; or</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    other method permitted pursuant to applicable law.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
selling stockholders may also sell securities under Rule&#160;144 or any other exemption from registration under the Securities Act,
if available, rather than under this prospectus.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broker-dealers
engaged by the selling stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions
or discounts from each selling stockholder (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser)
in amounts to be negotiated, but, except as set forth in a supplement to this prospectus, in the case of an agency transaction not in
excess of a customary brokerage commission in compliance with FINRA Rule&#160;2121; and in the case of a principal transaction a markup
or markdown in compliance with FINRA Rule&#160;2121.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the sale of the securities or interests therein, the selling stockholders may enter into hedging transactions with broker-dealers
or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they
assume. The selling stockholders may also sell securities short and deliver these securities to close out their short positions, or loan
or pledge the securities to broker-dealers that in turn may sell these securities. The selling stockholders may also enter into option
or other transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the
delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer
or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
selling stockholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be &#8220;underwriters&#8221;
within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers
or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts
under the Securities Act. The selling stockholders have informed us that they do not have any written or oral agreement or understanding,
directly or indirectly, with any person to distribute the securities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
resale securities will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws.
In addition, in certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for
sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
applicable rules and regulations under the Exchange&#160;Act, any person engaged in the distribution of the resale securities may not
simultaneously engage in market making activities with respect to the common stock for the applicable restricted period, as defined in
Regulation&#160;M, prior to the commencement of the distribution. In addition, the selling stockholders will be subject to applicable
provisions of the Exchange&#160;Act and the rules and regulations thereunder, including Regulation&#160;M, which may limit the timing
of purchases and sales of the common stock by the selling stockholder or any other person. We will make copies of this prospectus available
to the selling stockholders and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to
the time of the sale (including by compliance with Rule&#160;172 under the Securities Act).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 20; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_009"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LEGAL
MATTERS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
validity of the shares of the common stock offered by this prospectus will be passed upon for us by Pearl Cohen Zedek Latzer Baratz LLP,
New York, NY. Certain legal matters in connection with this offering relating to U.S. law will be passed upon for us by Greenberg Traurig,
LLP, New&#160;York, NY.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="a_010"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXPERTS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements incorporated in this Prospectus by reference to the Annual Report on Form 10-K for the year ended December 31, 2023
have been so included in reliance on the report (which contains an explanatory paragraph relating to the Company&#8217;s ability to continue
as a going concern as described in Note 1b to the financial statements) of Kesselman &amp; Kesselman, Certified Public Accountants (Isr.),
a member firm of PricewaterhouseCoopers International Limited, an independent registered public accounting firm, given on the authority
of said firm as experts in auditing and accounting.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="a_011"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WHERE
YOU CAN FIND MORE INFORMATION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have filed a registration statement on Form&#160;S-1 with the SEC under the Securities Act&#160;with respect to the securities offered
in this prospectus. This prospectus, which is filed as part of a registration statement, does not contain all of the information set
forth in the registration statement, some portions of which have been omitted in accordance with the SEC&#8217;s rules and regulations.
Statements made in this prospectus as to the contents of any contract, agreement or other document referred to in this prospectus are
not necessarily complete and are qualified in their entirety by reference to each such contract, agreement or other document that is
filed as an exhibit to the registration statement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
can read our SEC filings, including the registration statement, over the internet at the SEC&#8217;s website. Upon completion of this
offering, we will be subject to the information reporting requirements of the Exchange&#160;Act, and we will file reports, proxy statements
and other information with the SEC.&#160;The SEC&#8217;s website contains reports, proxy and information statements and other information
regarding registrants that file electronically with the SEC.&#160;The address of that site is <i>http://www.sec.gov</i>.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also maintain a website at <i>www.Actelis.com</i>, at which you may access these materials free of charge as soon as reasonably practicable
after they are electronically filed with, or furnished to, the SEC.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>However,
the information contained in or accessible through our website is not part of this prospectus or the registration statement of which
this prospectus forms a part, and investors should not rely on such information in making a decision to purchase our common stock in
this offering.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 21; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="a_012"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INCORPORATION
OF CERTAIN INFORMATION BY REFERENCE</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC allows us to &#8220;incorporate by reference&#8221; information into this prospectus. This means that we can disclose important information
to you by referring you to another document filed separately with the SEC. The information that we incorporate by reference is considered
to be part of this prospectus. Because we are incorporating by reference our future filings with the SEC, this prospectus is continually
updated and those future filings may modify or supersede some or all of the information included or incorporated in this prospectus.
This means that you must look at all of the SEC filings that we incorporate by reference to determine if any of the statements in this
prospectus or in any document previously incorporated by reference have been modified or superseded.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus incorporates by reference the documents listed below that have been previously filed with the SEC:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    Annual Report on <a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390024026069/ea0202031-10k_actelis.htm">Form 10-K</a> for the fiscal year ended December 31, 2023, filed with the SEC on March 26, 2024;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    Quarterly Report on <a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390024043030/ea0205455-10q_actelisnet.htm">Form 10-Q</a> for quarter ended March 31, 2024 filed with the SEC on May 14, 2024;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    Current Reports on Form 8-K filed with the SEC on <a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390024001929/ea191185-8k_actelis.htm">January 8, 2024</a>, <a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390024012307/ea193444-8k_actelis.htm">February 12, 2024</a>, <a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390024014088/ea193785-8k_actelis.htm">February 14, 2024</a>, <a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390024022669/ea0201793-8k_actelis.htm">March 14, 2024</a>, <a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390024050213/ea0207418-8k_actelis.htm">June 6, 2024</a>, <a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390024052913/ea0207902-8k_actelis.htm">June 14, 2024</a>, <a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390024053826/ea0208055-8k_actelis.htm">June 18, 2024</a>, <a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390024054363/ea0208208-8k_actelis.htm">June 20, 2024</a>, <a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390024056884/ea0208695-8k_actelis.htm">June 28, 2024</a>, <a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390024058192/ea0208772-8k_actelis.htm">July 2, 2024</a> and <a href="http://www.sec.gov/Archives/edgar/data/1141284/000101376224000752/ea0209946-8k_actelis.htm">July 24, 2024</a>;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    description of our common stock, which is contained in the registration statement on <a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022023871/ea159353-8a12b_actelis.htm">Form 8-A</a> filed with the SEC on May 4, 2022 (File
    No. 001-41375).</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also incorporate by reference all future documents (excluding information furnished pursuant to Items 2.02 and 7.01 of Form 8-K) we file
with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act, subsequent to the date of this prospectus
and prior to the termination of the offering.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should rely only on the information incorporated by reference or provided in this prospectus. We have not authorized anyone else to provide
you with different information. Any statement contained in a document incorporated by reference into this prospectus will be deemed to
be modified or superseded for the purposes of this prospectus to the extent that a later statement contained in this prospectus or in
any other document incorporated by reference into this prospectus modifies or supersedes the earlier statement. Any statement so modified
or superseded will not be deemed, except as so modified or superseded, to constitute a part of this prospectus. You should not assume
that the information in this prospectus is accurate as of any date other than the date of this prospectus or the date of the documents
incorporated by reference in this prospectus.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The information about us contained
in this prospectus should be read together with the information in the documents incorporated by reference. You may request a copy of
any or all of these filings, at no cost, by writing or telephoning us at Yoav Efron, Chief Financial Officer and Deputy Chief Executive
Officer, 4039 Clipper Court, Fremont, CA 94538 USA, telephone number +1-510-545-1045 or by emailing us at yoave@actelis.com.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 22; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><img alt="" src="image_001.jpg"/><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Actelis
Networks, Inc.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRELIMINARY
PROSPECTUS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;
<b>, 2024</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 23 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART&#160;II</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INFORMATION
NOT REQUIRED IN PROSPECTUS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;13.
OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the costs and expenses payable by the Company in connection with this offering. All expenses incurred with
respect to the registration of the common stock will be borne by the Company. All amounts are estimates, except the SEC registration
fee.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left; text-indent: -10pt; padding-left: 10pt">SEC registration fee</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">470.37</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Printing expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Accounting fees and expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">Legal fees and expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,500</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 4pt; text-indent: -10pt; padding-left: 20pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">26,970.37</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;14.
INDEMNIFICATION OF DIRECTORS AND OFFICERS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&#160;102(b)(7)&#160;of
the Delaware General Corporation Law (the &#8220;Delaware Law&#8221;) enables a corporation, in its original certificate of incorporation
or an amendment thereto, to eliminate or limit the personal liability of a director for monetary damages for breach of the director&#8217;s
fiduciary duty, except (i)&#160;for any breach of the director&#8217;s duty of loyalty to the corporation or its stockholders, (ii)&#160;for
acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii)&#160;pursuant to Section&#160;174
of the Delaware Law (providing for liability of directors for unlawful payment of dividends or unlawful stock purchases or redemptions),
or (iv)&#160;for any transaction from which the director derived an improper personal benefit. The Company&#8217;s Sixth Amended and
Restated Certificate of Incorporation, as amended (&#8220;Certificate of Incorporation&#8221;), contains such a provision.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, Section&#160;145 of the Delaware Law provides that a corporation may indemnify any persons, including officers and directors,
who are, or are threatened to be made, party to any threatened, pending or completed legal action, suit or proceeding, whether civil,
criminal, administrative or investigative (other than an action by or in the right of the corporation), by reason of the fact that such
person is or was an officer, director, employee or agent of the corporation, or is or was serving at the request of such corporation
as a director, officer, employee or agent of another corporation or enterprise. The indemnity may include expenses (including attorneys&#8217;
fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action,
suit or proceeding, provided such officer, director, employee or agent acted in good faith and in a manner the person reasonably believed
to be in or not opposed to the corporation&#8217;s best interests and, with respect to criminal proceedings, had no reasonable cause
to believe that the person&#8217;s conduct was unlawful. A Delaware corporation may indemnify officers or directors in an action by or
in the right of the corporation under the same conditions, except that no indemnification is permitted without judicial approval if the
officer or director is adjudged to be liable to the corporation. Where an officer or director is successful on the merits or otherwise
in the defense of any action referred to above, the corporation must indemnify him or her against expenses (including attorneys&#8217;
fees) that he or she actually and reasonably incurred.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s Certificate of Incorporation and Restated Bylaws provide for indemnification of directors and officers to the fullest
extent permitted by the Delaware Law.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 24; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
15. RECENT SALES OF UNREGISTERED SECURITIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following information represents securities sold by the Company within the past three years which were not registered under the Securities
Act.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">On
June 30, 2024, we entered into an inducement letter with the holder of our June 2024 Warrants. Pursuant to the inducement letter, the
holder agreed to exercise for cash 999,670 of its June 2024 Warrants </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
purchase an aggregate of 999,670 shares of our common stock at an exercise price of $2.00 <span>per share,
in consideration of our agreement to issue the July 2024 Warrants to purchase up to an aggregate of 1,999,340 shares of our common stock,
at an exercise price of $1.75 per share. We also agreed to issue to the Placement Agent 69,977 shares of common stock at an exercise
price of $2.50 per share and a term of </span>five and one-half years<span>. Our total aggregate gross
proceeds were approximately $2.25 million, and the transaction closed on July 2, 2024. </span></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 5, 2024, we entered into an inducement letter with the holder of our May 2023 Warrants. Pursuant to the inducement letter, the holder
agreed to exercise for cash its May 2023 Warrants to purchase an aggregate of 999,670 shares of our common stock at an exercise price
of $2.75 per share, in consideration of our agreement to issue the June 2024 Warrants to purchase up to an aggregate of 1,999,340 shares
of our common stock, at an exercise price of $2.00 per share. We also agreed to issue to the Placement Agent 69,977 shares of common
stock at an exercise price per share of $3.4375 and a term of five and one-half years. Our total aggregate gross proceeds were approximately
$3.0 million, and the transaction closed on June 6, 2024.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December&#160;17, 2023, we entered into a securities purchase agreement with an Investor,&#160;pursuant to which we agreed to issue and
sell to the Investor in a private placement (i)&#160;301,000 shares of our common stock, (ii) 970,187 pre-funded warrants to purchase
up to 970,187 shares of our common stock and (iii) 1,271,187 shares of common stock issuable upon the exercise of common warrants, at
a purchase price of $1.18 per share of common stock and related common warrant, or $1.1799 per pre-funded warrant and related common
warrant, for a total aggregate gross proceeds of approximately $1.5 million.&#160; The offering closed on December&#160;20, 2023. The
common warrants have an exercise price of $1.18 per share, are exercisable immediately upon issuance and expire five and one-half years
following the issuance. The pre-funded warrants were sold in lieu of shares of common stock, are exercisable immediately upon issuance,
have an exercise price of $0.0001 per share and expire when exercised in full. We also agreed to issue to H.C. Wainwright &amp; Co.,
LLC, the Placement Agent, 88,983 shares of common stock at an exercise price per share of $1.475 and a term of five and one-half years.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 4, 2023, we entered into a securities purchase agreement with an Investor, pursuant to which we agreed to issue and sell to the Investor
in a private placement (i) 190,000 shares of our common stock, (ii) 754,670 pre-funded warrants to purchase up to 754,670 shares of our
common stock and (iii) 944,670 shares of common stock issuable upon the exercise of common warrants, at a purchase price of $3.705 per
share of common stock and related common warrant, or $3.7049 per pre-funded warrant and related common warrant, for a total aggregate
gross proceeds of approximately $3.5 million. The Offering closed on May 8, 2023. Following an amendment in September 2023, the common
warrants now have an exercise price of $2.75 per share, are exercisable immediately upon issuance and expire five and one-half years
following the issuance. The pre-funded warrants were sold in lieu of shares of common stock, are exercisable immediately upon issuance,
have an exercise price of $0.0001 per share and expire when exercised in full. We also agreed to issue to H.C. Wainwright &amp; Co.,
LLC, the Placement Agent, 66,127 shares of common stock at an exercise price per share of $4.6313 and a term of five and one-half years.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 8, 2023, we issued to H.C. Wainwright &amp; Co., LLC an additional 55,000 shares of common stock issuable upon the exercise
of common warrants, at a purchase price of $2.75 per share. As part of the December 2023 Private Placement, we agreed, subject to our
shareholders approval, which has not yet been obtained, to amend the exercise price of the warrants to $1.18 per share.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities above were offered and sold pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities
Act since, among other things, the transactions did not involve a public offering.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 25; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;16.
EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
Exhibits.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 9%; border-bottom: black 1.5pt solid; padding-right: 3pt; padding-bottom: 1.5pt"><span style="font-size: 10pt"><b>Exhibit&#160;No.</b></span></td>
    <td style="white-space: nowrap; width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 90%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-size: 10pt">3.1</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022025173/fs12022a4ex3-5_actelisnet.htm"><span style="font-size: 10pt">Form of the Twenty-Fourth Amended and Restated Certificate of Incorporation of the Registrant, dated May 2, 2022 (as filed as Exhibit 3.5 to the Company&#8217;s Form S-1/A, filed on May 10, 2022)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">3.2</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022023064/fs12022a1ex3-4_actelisnet.htm"><span style="font-size: 10pt">Amended and Restated Bylaws of Actelis Networks, Inc. (as filed as Exhibit 3.4 to the Company&#8217;s Form S-1/A, filed on May 10, 2022)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-size: 10pt">4.1</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390023024106/f10k2022ex4-1_actelisnet.htm"><span style="font-size: 10pt">Description of Securities (filed as Exhibit 4.1 to the Company&#8217;s Form&#160;10-K for the fiscal year ended December&#160;31, 2022, filed on March&#160;29, 2023)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">4.2</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022023064/fs12022a1ex4-1_actelisnet.htm"><span style="font-size: 10pt">Form of Representative&#8217;s Warrant (as filed as Exhibit 4.1 to the Company&#8217;s Form&#160;S-1/A, filed on May&#160;2, 2022)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-size: 10pt">4.3</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390023037340/ea178132ex4-1_actelis.htm"><span style="font-size: 10pt">Form of Common Warrant (as filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form&#160;8-K, filed on May&#160;8, 2023)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">4.4</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390023037340/ea178132ex4-2_actelis.htm"><span style="font-size: 10pt">Form of Pre-Funded Warrant (as filed as Exhibit 4.2 to the Company&#8217;s Current Report on Form&#160;8-K, filed on May&#160;8, 2023)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-size: 10pt">4.5</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390023037340/ea178132ex4-3_actelis.htm"><span style="font-size: 10pt">Form of Placement Agent Warrant (as filed as Exhibit 4.3 to the Company&#8217;s Current Report on Form&#160;8-K, filed on May&#160;8, 2023)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">4.6</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390023097390/ea190433ex4-1_actelis.htm"><span style="font-size: 10pt">Form of Common Warrant (as filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form&#160;8-K, filed on December&#160;20, 2023)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-size: 10pt">4.7</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390023097390/ea190433ex4-2_actelis.htm"><span style="font-size: 10pt">Form of Pre-Funded Warrant (as filed as Exhibit 4.2 to the Company&#8217;s Current Report on Form&#160;8-K, filed on December&#160;20, 2023)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">4.8</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390023097390/ea190433ex4-3_actelis.htm"><span style="font-size: 10pt">Form of Placement Agent Warrant (as filed as Exhibit 4.3 to the Company&#8217;s Current Report on Form&#160;8-K, filed on December&#160;20, 2023)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-size: 10pt">4.9</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390024014088/ea193785ex4-1_actelis.htm"><span style="font-size: 10pt">Form of Credit Agreement (as filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K, as filed on February 14, 2024).</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">5.1*</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="ea021013401ex5-1_actelis.htm"><span style="font-size: 10pt">Opinion of Pearl Cohen Latzer Zedek Baratz LLP</span></a></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-size: 10pt">10.1</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022023064/fs12022a1ex10-2_actelisnet.htm"><span style="font-size: 10pt">Lease by and between Actelis Networks Israel, Ltd. and Moshe Smucha, dated January&#160;13, 2000 (as&#160;filed as Exhibit 10.2 to the Company&#8217;s Form&#160;S-1/A, filed on May&#160;2, 2022)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.2</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022023064/fs12022a1ex10-3_actelisnet.htm"><span style="font-size: 10pt">First Amendment to the Lease and Management Agreements from October&#160;22, 2017, by and between Homerton Investments, Ltd. and Actelis Networks Israel Ltd., dated April&#160;14, 2021 (as filed as Exhibit 10.3 to the Company&#8217;s Form&#160;S-1/A, filed on May&#160;2, 2022)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-size: 10pt">10.3</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022020064/fs12022ex10-9_actelisnet.htm"><span style="font-size: 10pt">Employment Agreement between Actelis Networks, Inc. and Mr.&#160;Tuvia Barlev dated February&#160;15, 2015 (as filed as Exhibit 10.9 to the Company&#8217;s Form&#160;S-1/A, filed on May&#160;2, 2022)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.4</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022020064/fs12022ex10-10_actelisnet.htm"><span style="font-size: 10pt">Offer letter between Actelis Networks, Inc. and Mr.&#160;Yoav Efron dated November&#160;30, 2017 (as furnished as Exhibit 10.10 to the Company&#8217;s Form&#160;S-1/A, filed on May&#160;10, 2022)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-size: 10pt">10.5</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022023064/fs12022a1ex10-11_actelisnet.htm"><span style="font-size: 10pt">Employment Agreement between Actelis Networks Israel, Ltd. And Mr.&#160;Yoav Efron dated November&#160;30, 2017 (as furnished as Exhibit 10.11 to the Company&#8217;s Form&#160;S-1/A, filed on May&#160;10, 2022)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.6</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022020064/fs12022ex10-12_actelisnet.htm"><span style="font-size: 10pt">Consulting Agreement between Actelis Networks, Inc. and Barlev Enterprises dated February&#160;20, 2015 (as furnished as Exhibit 10.12 to the Company&#8217;s Form&#160;S-1/A, filed on May&#160;10, 2022)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-size: 10pt">10.7</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022020064/fs12022ex10-13_actelisnet.htm"><span style="font-size: 10pt">Actelis Networks, Inc. 2015 Equity Incentive Plan (as filed as Exhibit 10.13 to the Company&#8217;s Form&#160;S-1, filed on April&#160;15, 2022)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.8</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022020064/fs12022ex10-14_actelisnet.htm"><span style="font-size: 10pt">Amendment No. 1 to 2015 Equity Incentive Plan (as filed as Exhibit 10.14 to the Company&#8217;s Form&#160;S-1, filed on April&#160;15, 2022)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-size: 10pt">10.9</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022020064/fs12022ex10-16_actelisnet.htm"><span style="font-size: 10pt">Senior Loan Agreement between Migdalor Business Investment Fund and Actelis Networks Israel, Ltd., dated December&#160;2, 2020 (as filed as Exhibit 10.16 to the Company&#8217;s Form&#160;S-1, filed on April&#160;15, 2022)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.10</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022020064/fs12022ex10-17_actelisnet.htm"><span style="font-size: 10pt">Amendment Number 1 to Senior Loan Agreement between Migdalor Business Investment Fund and Actelis Networks Israel, Ltd., dated November&#160;17, 2021 (as filed as Exhibit 10.17 to the Company&#8217;s Form&#160;S-1, filed on April&#160;15, 2022)</span></a></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 26; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 9%; text-align: justify"><span style="font-size: 10pt">10.11</span></td>
    <td style="white-space: nowrap; width: 1%; padding-bottom: 2.25pt">&#160;</td>
    <td style="width: 90%; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022020064/fs12022ex10-18_actelisnet.htm"><span style="font-size: 10pt">Securities Purchase and Loan Repayment Agreement between Actelis Networks, Inc. and Mr.&#160;Tuvia Barlev dated April&#160;15, 2022 (as filed as Exhibit 10.18 to the Company&#8217;s Form&#160;S-1, filed on April&#160;15, 2022)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.12</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390023037340/ea178132ex10-1_actelis.htm"><span style="font-size: 10pt">Form of Securities Purchase Agreement (as filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form&#160;8-K, filed on May&#160;8, 2023)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.13</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390023037340/ea178132ex10-2_actelis.htm"><span style="font-size: 10pt">Form of Registration Rights Agreement (as filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form&#160;8-K, filed on May&#160;8, 2023)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.14</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390023097390/ea190433ex10-2_actelis.htm"><span style="font-size: 10pt">Form of Warrant Amendment (as filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K, filed on December 20, 2023)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.15</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390023097390/ea190433ex10-1_actelis.htm"><span style="font-size: 10pt">Form of Securities Purchase Agreement (as filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K, filed on December 20, 2023)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.16</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390023097390/ea190433ex10-2_actelis.htm"><span style="font-size: 10pt">Form of Warrant Amendment (as filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K, filed on December 20, 2023)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.17</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390023097390/ea190433ex10-3_actelis.htm"><span style="font-size: 10pt">Form of Registration Rights Agreement (as filed as Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K, filed on December 20, 2023)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.18</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390024050213/ea020741801ex10-1_actelis.htm"><span style="font-size: 10pt">Form of Inducement Letter (as filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K, filed on June 6, 2024)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.19</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390024050213/ea020741801ex10-2_actelis.htm"><span style="font-size: 10pt">Form of June 2024 Warrant (as filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on June 6, 2024)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.20</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390024050213/ea020741801ex10-3_actelis.htm"><span style="font-size: 10pt">Form of June 2024 Placement Agent Warrant (as filed as Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed on June 6, 2024).</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.21</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390024058192/ea020877201ex10-1_actelis.htm"><span style="font-size: 10pt">Form of Inducement Letter (as filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K, filed on July 2, 2024)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.22</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390024058192/ea020877201ex10-2_actelis.htm"><span style="font-size: 10pt">Form of July 2024 New Warrant (as filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on July 2, 2024)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.23</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390024058192/ea020877201ex10-3_actelis.htm"><span style="font-size: 10pt">Form of July 2024 Placement Agent Warrant (as filed as Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed on July 2, 2024).</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">21.1</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022020064/fs12022ex21-1_actelisnet.htm"><span style="font-size: 10pt">Subsidiaries of the Registrant (as filed as Exhibit 21.1 to the Company&#8217;s Form S-1, filed on April 15, 2022)</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">23.1*</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: left"><span style="font-size: 10pt"><a href="ea021013401ex23-1_actelis.htm">Consent of Kesselman &amp; Kesselman, Certified Public Accountants (Isr.) a member firm of PricewaterhouseCoopers International Limited, independent registered public accounting firm for the Company</a></span></td></tr>

<tr style="vertical-align: top; ">
    <td style="text-align: justify">24.1*</td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: left"><a href="#n_100">Power of Attorney</a></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Instance Document.</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Schema Document.</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Definition Linkbase Document.</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Label Linkbase Document.</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span></td></tr>

  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">107*</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><a href="ea021013401ex-fee_actelis.htm"><span style="font-size: 10pt">Filing Fee Table</span></a></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    herewith</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Financial Statement Schedules</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
financial statement schedules are omitted because the information required to be set forth therein is not applicable or is included in
the consolidated financial statements or related notes incorporated herein by reference.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b>&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 27; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;17.
UNDERTAKINGS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    undersigned registrant hereby undertakes:</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 72px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 96pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 96px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    include any prospectus required by section 10(a)(3)&#160;of the Securities Act;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 96pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 96px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent
    post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set
    forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if
    the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end
    of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule&#160;424(b)&#160;if,
    in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth
    in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 96pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 96px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    include any material information with respect to the plan of distribution not previously disclosed in the registration statement
    or any material change to such information in the registration statement;&#160;<i>provided</i>,&#160;<i>however</i>, that paragraphs
    (a)(1)(i), (a)(1)(ii), and (a)(1)(iii)&#160;of this section do not apply if the information required to be included in a post-effective
    amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant to section 13
    or section 15(d)&#160;of the Exchange&#160;Act&#160;that are incorporated by reference in the registration statement.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 72px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
    for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a
    new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be
    deemed to be the initial bona fide offering thereof.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 72px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
    termination of the offering.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 72px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
    for the purpose of determining liability under the Securities Act to any purchaser, each prospectus filed pursuant to Rule&#160;424(b)&#160;as
    part of a registration statement relating to an offering, other than registration statements relying on Rule&#160;430B or other than
    prospectuses filed in reliance on Rule&#160;430A, shall be deemed to be part of and included in the registration statement as of
    the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus
    that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration
    statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior
    to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the
    registration statement or made in any such document immediately prior to such date of first use.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Page; Sequence: 28; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 72px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
    for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution
    of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant
    to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities
    are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller
    to the purchaser and will be considered to offer or sell such securities to such purchaser:</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 96pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 96px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule&#160;424;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 96pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 96px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by
    the undersigned registrant;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 96pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 96px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant
    or its securities provided by or on behalf of the undersigned registrant; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 96pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 96px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
    insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling
    persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion
    of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In
    the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred
    or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding)
    is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will,
    unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction
    the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed
    by the final adjudication of such issue.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    undersigned registrant hereby undertakes:</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 72px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
    for the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus
    shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities
    at that time shall be deemed to be the initial bona fide offering thereof.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 72px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
    for purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as
    part of this registration statement in reliance upon Rule&#160;430A and contained in a form of prospectus filed by the registrant
    pursuant to Rule&#160;424(b)(1)&#160;or (4)&#160;or 497(h)&#160;under the Securities Act shall be deemed to be part of this registration
    statement as of the time it was declared effective.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 29; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act&#160;of&#160;1933, the registrant has duly caused this registration statement on Form S-1 to
be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Freemont, California on July 29, 2024.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ACTELIS
    NETWORKS, INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 36%; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Tuvia Barlev</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tuvia
    Barlev</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Secretary</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="n_100"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>POWER
OF ATTORNEY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KNOW
ALL MEN BY THESE PRESENTED, that each director and officer of Actelis Networks, Inc. whose signature appears below hereby appoints Tuvia
Barlev and Yoav Efron, and each of them severally, acting alone and without the other, his/her true and lawful attorney-in-fact with
full power of substitution or re-substitution, for such person and in such person&#8217;s name, place and stead, in any and all capacities,
to sign on such person&#8217;s behalf, individually and in each capacity stated below, any and all amendments, including post-effective
-amendments to this Registration Statement, and to sign any and all additional registration statements relating to the same offering
of securities of the Registration Statement that are filed pursuant to Rule 462(b) of the Securities Act of 1933, and to file the same,
with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said
attorneys-in-fact, full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about
the premises, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that
said attorneys-in-fact, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Signature</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 18%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Tuvia Barlev</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Chairman of the Board of Directors</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    29, 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tuvia
    Barlev</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    <i>Yoav Efron</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer and Deputy Chief Executive Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    29, 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yoav
    Efron</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial Officer and Principal Accounting Officer)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Joseph Moscovitz</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    29, 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph
    Moscovitz</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Gideon Marks</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    29, 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gideon
    Marks</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Israel Niv</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    29, 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel
    Niv</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">II-7</span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>



</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag" id="ixv-3646">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-3647">0001141284</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="asns-20240331.xsd" xlink:type="simple"/></ix:references>
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><xbrli:context xmlns="" id="c0">
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrb8xOYtPeNESS0HWLdfr4iJuQUueersOTwI6y96qaPrzmCkI4XgUC/a77N1YAxjVvK6XJ/t3hMDB9h6bm/YJY9/Cfosp6rHHihBSXm+WUhImH/p8fDoXIJWn1l7wWOxO4Wgm0T7u8NTQ1gd173I/ypiFG+doEzErmrChuCObD9h86POgBnnZkYGL3zimT/q1v6ZVyD8nLwXJEC0kqn5sELkMUUW4TSwQ2g=] CSR-->
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001141284</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context></ix:resources></ix:header>

</div></div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ea021013401ex5-1_actelis.htm
<DESCRIPTION>OPINION OF PEARL COHEN LATZER ZEDEK BARATZ LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0 0pt"><B>Exhibit 5.1</B></P>

<P STYLE="margin: 0 0pt">&nbsp;</P>

<P STYLE="margin: 0 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 33%"><IMG SRC="ex5-1_001.jpg" ALT=""></TD>
  <TD STYLE="padding-top: 3pt; width: 36%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Pearl
                         Cohen Zedek Latzer Baratz LLP</FONT></P>
</TD>
  <TD STYLE="width: 31%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Page 1 of 3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right">July 29, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Actelis Networks, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">4039 Clipper Court</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Fremont, CA 94583</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">Re:</TD><TD STYLE="text-align: justify">Registration Statement on Form S-1 </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We have acted
as counsel to Actelis Networks, Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), in connection with the Registration Statement
on Form S-1 filed by the Company under the Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;), with the United
States Securities and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;) on the date hereof (the &ldquo;<B>Registration Statement</B>&rdquo;).
The Registration Statement relates to the offering and sale from time to time of up to 2,069,317 shares of the Company&rsquo;s common
stock, $0.0001 par value per share (&ldquo;<B>Common Stock</B>&rdquo;), by the selling stockholders identified in the Registration Statement
(the &ldquo;<B>Selling Stockholders</B>&rdquo;) consisting of (a) 1,999,340 shares of our Common Stock (the &ldquo;<B>Inducement Warrant
Shares</B>&rdquo;) underlying warrants issued to one holder (the &ldquo;<B>Holder</B>&rdquo;), pursuant to that certain inducement letter,
dated June 30, 2024, between the Company and the Holder (the &ldquo;<B>Inducement Letter</B>,&rdquo; and collectively the &ldquo;<B>Inducement
Warrants</B>&rdquo;) and (b) 69,977 shares of the Company&rsquo;s common stock, $0.0001 par value per share (the &ldquo;<B>Placement Agent Warrant
Shares</B>,&rdquo; and together with the Inducement Warrant Shares, the &ldquo;<B>Shares</B>&rdquo;) underlying certain warrants issued
to H.C. Wainwright &amp; Co., LLC or its representatives (the &ldquo;<B>Placement Agent Warrants</B>, and together with the Inducement
Warrants, the &ldquo;<B>Warrants</B>&rdquo;, and together with the Shares, the &ldquo;<B>Securities</B>&rdquo;) for serving as the placement
agent in connection with the Inducement Letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">In connection
with this opinion, we have examined and relied upon the Registration Statement; the Company&rsquo;s certificate of incorporation, as amended
and restated to date; the Inducement Letter; the Company&rsquo;s Bylaws as in effect on the date hereof; the Warrants; and certain resolutions
and minutes of meetings of the Board of Directors of the Company relating to the issuance of the Securities and the Registration Statement.
We have considered such matters of law and of fact, including the examination of originals or copies, certified or otherwise identified
to our satisfaction, of such records, documents, certificates, and other instruments of the Company, certificates of officers, directors
and representatives of the Company, certificates of public officials, and such other documents as in our judgment are necessary or appropriate
to enable us to render the opinion expressed below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">BOSTON &#9679; NEW YORK &#9679; LOS ANGELES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 33%"><IMG SRC="ex5-1_001.jpg" ALT=""></TD>
  <TD STYLE="padding-top: 3pt; width: 36%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Pearl
                         Cohen Zedek Latzer Baratz LLP</FONT></P>
</TD>
  <TD STYLE="width: 31%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Page 2 of 3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">As to matters
of fact material to our opinions, we have relied, without independent verification, on certificates and other inquiries of officers of
the Company. We have assumed without investigation the genuineness and authenticity of all documents submitted to us as originals, the
conformity to originals of all documents submitted to us as copies thereof, and the due execution and delivery of all documents where
due execution and delivery are a prerequisite to the effectiveness thereof, the accuracy and completeness of
all records made available to us by the Company, and that all offers and sales of the Securities will be made in compliance with the securities
laws of the states having jurisdiction thereof. We have also assumed that (i) the Registration Statement and any amendments thereto (including
post-effective amendments) have become effective and will continue to be effective at the time of the resale of any Securities, (ii) if
necessary, a prospectus supplement will have been prepared and filed with the Commission describing any Securities offered thereby or
any Selling Stockholders, (iii) all Securities will be sold in the manner stated in the Registration Statement and, if necessary, the
applicable prospectus supplement, and (iv) at the time of the offering, there will not have occurred any changes in the law affecting
the authorization, execution, delivery, validity or enforceability of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The opinions set forth
in this letter are limited solely to the federal laws of the United States of America and the State of Delaware, and we express no opinion
as to the laws of any other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Based upon
the foregoing and subject to the qualifications, assumptions and limitations stated herein, we are of the opinion that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-left: 2.5pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">(i)</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2.6pt">The Warrants have been
    duly authorized by all necessary corporate action on the part of the Company and constitute the legally valid and binding obligation
    of the Company, enforceable against the Company in accordance with their terms, except as may be limited by bankruptcy, insolvency,
    reorganization, moratorium or similar laws relating to or affecting creditors&rsquo; rights generally (including, without
    limitation, fraudulent conveyance laws) and by general principles of equity, including, without limitation, concepts of materiality,
    reasonableness, good faith and fair dealing and the possible unavailability of specific performance or injunctive relief, regardless
    of whether considered in a proceeding in equity or at law; and</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.25in; font-size: 10pt"><FONT STYLE="font-size: 10pt">(ii)</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Upon the issuance, payment for and delivery of the Shares in accordance
with the applicable Warrants, the Shares will be validly issued, fully paid and non-assessable.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We consent
to the reference to our firm under the caption &ldquo;Legal Matters&rdquo; in the Registration Statement and to the filing of this opinion
as an exhibit to the Registration Statement. In giving our consent, we do not admit that we are &ldquo;experts&rdquo; within the meaning
of Section 11 of the Securities Act or within the category of persons whose consent is required by Section 7 of the Securities Act or
the rules and regulations of the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">BOSTON &#9679; NEW YORK &#9679; LOS ANGELES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.95pt"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.95pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.95pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 33%"><IMG SRC="ex5-1_001.jpg" ALT=""></TD>
  <TD STYLE="padding-top: 3pt; width: 36%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Pearl
                         Cohen Zedek Latzer Baratz LLP</FONT></P>
</TD>
  <TD STYLE="width: 31%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Page 3 of 3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">/s/ Pearl Cohen Zedek Latzer Baratz LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">Pearl Cohen Zedek Latzer Baratz LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">BOSTON &#9679; NEW YORK &#9679; LOS ANGELES</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ea021013401ex23-1_actelis.htm
<DESCRIPTION>CONSENT OF KESSELMAN & KESSELMAN, CERTIFIED PUBLIC ACCOUNTANTS (ISR.) A MEMBER FIRM OF PRICEWATERHOUSECOOPERS INTERNATIONAL LIMITED, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE COMPANY
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the incorporation by reference in this Registration Statement on Form S-1 of Actelis Networks, Inc. of our report dated
March 26, 2024 relating to the financial statements, which appears in Actelis Networks, Inc.&rsquo;s Annual Report on Form 10-K for the
year ended December 31, 2023. We also consent to the reference to us under the heading &ldquo;Experts&rdquo; in such Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Kesselman &amp; Kesselman</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certified Public Accountants (Isr.)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A member firm of PricewaterhouseCoopers International Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel-Aviv,
Israel<BR>
July 29, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>ea021013401ex-fee_actelis.htm
<DESCRIPTION>FILING FEE TABLE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 107</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Calculation of Filing Fee Tables</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form S-1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Form Type)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Actelis Networks, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in its Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Table 1: Newly Registered Securities</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Security<BR> Type</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Security<BR> Class<BR> Title</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fee<BR> Calculation<BR> Or Carry<BR> Forward<BR> Rule</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount<BR> Registered<SUP>(1)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposed<BR> Maximum<BR> Offering<BR> Price Per<BR> Share<SUP>(2)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum<BR> Aggregate<BR> Offering<BR> Price<SUP>(2)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fee<BR> Rate</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount<BR> of<BR> Registration<BR> Fee</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 10%; text-align: left">Fees to Be Paid</TD><TD STYLE="width: 0.5%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 10%; text-align: center; padding-bottom: 1.5pt">Equity</TD><TD STYLE="width: 0.5%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 20%; text-align: center; padding-bottom: 1.5pt">Common Stock, $0.0001 par value per share</TD><TD STYLE="width: 0.5%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 0.5%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="vertical-align: top; width: 10%; padding-bottom: 1.5pt; text-align: center">457 (c)</TD><TD STYLE="width: 0.5%; padding-bottom: 1.5pt; text-align: left"></TD><TD STYLE="width: 0.5%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 0.5%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; padding-bottom: 1.5pt; text-align: right">2,069,317</TD><TD STYLE="width: 0.5%; padding-bottom: 7pt; text-align: left"><SUP>(3)</SUP></TD><TD STYLE="width: 0.5%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 0.5%; padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="width: 8%; padding-bottom: 1.5pt; text-align: right">1.54</TD><TD STYLE="width: 0.5%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 0.5%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 0.5%; padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="width: 8%; padding-bottom: 1.5pt; text-align: right">3,186,748.18</TD><TD STYLE="width: 0.5%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 0.5%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 0.5%; padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="width: 8%; padding-bottom: 1.5pt; text-align: right">0.0001476</TD><TD STYLE="width: 0.5%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 0.5%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 0.5%; border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="width: 8%; border-bottom: Black 1.5pt solid; text-align: right">470.37</TD><TD STYLE="width: 0.5%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-weight: bold; text-align: right; padding-bottom: 1.5pt">Total Offering Amounts</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">3,186,748.18</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">470.37</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-weight: bold; text-align: right; padding-bottom: 1.5pt">Total Fees Previously Paid</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-weight: bold; text-align: right; padding-bottom: 1.5pt">Total Fee Offsets</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-weight: bold; text-align: right; padding-bottom: 4pt">Net Fees Due</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">470.37</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to Rule 416 under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), this registration statement shall also cover any additional shares of common stock, par value $0.0001 per share (&ldquo;Common Stock&rdquo;), of Actelis Networks, Inc that may be issued in connection with a stock dividend, stock split, recapitalization or similar transactions.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457 under the Securities Act, based on the average of the high and low prices of the Common Stock on the Nasdaq Capital market on July 26, 2024.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of (i) 1,999,340 shares of common stock issuable upon the exercise of new warrants issued to a certain holder in connection with the warrant repricing and (ii) 69,977 shares of common stock issuable upon the exercise of new warrants issued to the placement agent in connection with the warrant repricing.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !+ 0T# 2(  A$! Q$!_\0
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M2^PV5%[!X@OK/PE>B,!<^#X,$L"3_,50!_IMG_@]6_X)T $C]G3]KYB 2 -
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MY:'^B'_P3&_X+B?L0>$?V,?V(/V0?%GQX\5Z?\5?#7PW^'7P;F\$VO@7Q/\
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ML-3N89$NA^*D_P#P>N?MY/K N;?]F']EN#1 W.DR/\2Y[YE+< :P/%<48(7
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MKHVE6_V73=._9X\$6MG;>=//Y,$=M)L3SKF6:>3;DX:65W]6-?I;0!_E??\
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JB/Q7I_AF[7<2EQX?LM-E1CO5P^&K^DHQH225!)ZGN<=,GOCMZ=* /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  K ,P# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^;>BBBOU
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MTB]ACN+/5-:\$^#/$/BC0+*YMY 4NHWUK2[&;[.=V]X%^0XKY(\9^*=<\?\
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M6ES"^H6RVMM-A[S<YAR$R=)+VE-J\]:D$TX[)3W5]6O/:VK9K3ERN7G%[O\
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' 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>asns-20240331.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Jul 29 19:49:55 UTC 2024 -->
<xs:schema elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2024" targetNamespace="http://www.actelis.com/20240331" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:asns="http://www.actelis.com/20240331" xmlns:dtr="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="asns-20240331_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="asns-20240331_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="asns-20240331_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrb8xOYtPeNESS0HWLdfr4iJuQUueersOTwI6y96qaPrzmCkI4XgUC/a77N1YAxjVvK6XJ/t3hMDB9h6bm/YJY9/Cfosp6rHHihBSXm+WUhImH/p8fDoXIJWn1l7wWOxO4Wgm0T7u8NTQ1gd173I/ypiFG+doEzErmrChuCObD9h86POgBnnZkYGL3zimT/q1v6ZVyD8nLwXJAVtvs+6SWSZBwaCFn10Cqg=] CSR-->
      <link:roleType roleURI="http://www.actelis.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2024" schemaLocation="https://xbrl.sec.gov/sic/2024/sic-2024.xsd"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="asns_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>asns-20240331_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Jul 29 19:49:55 UTC 2024 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="asns-20240331.xsd#DocumentAndEntityInformation" roleURI="http://www.actelis.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:role="http://www.actelis.com/role/DocumentAndEntityInformation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrb8xOYtPeNESS0HWLdfr4iJuQUueersOTwI6y96qaPrzmCkI4XgUC/a77N1YAxjVvK6XJ/t3hMDB9h6bm/YJY9/Cfosp6rHHihBSXm+WUhImH/p8fDoXIJWn1l7wWOxO4Wgm0T7u8NTQ1gd173I/ypiFG+doEzErmrChuCObD9h86POgBnnZkYGL3zimT/q1v6ZVyD8nLwXJIYzBGKxG6RJ6Lst+pB6RqE=] CSR-->
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="9" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>asns-20240331_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Jul 29 19:49:55 UTC 2024 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrb8xOYtPeNESS0HWLdfr4iJuQUueersOTwI6y96qaPrzmCkI4XgUC/a77N1YAxjVvK6XJ/t3hMDB9h6bm/YJY9/Cfosp6rHHihBSXm+WUhImH/p8fDoXIJWn1l7wWOxO4Wgm0T7u8NTQ1gd173I/ypiFG+doEzErmrChuCObD9h86POgBnnZkYGL3zimT/q1v6ZVyD8nLwXJFsjEBabeKHiUS2ygwXFZNc=] CSR-->
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl0" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl0" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl0" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl0" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl0" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl0" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl0" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>asns-20240331_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Jul 29 19:49:55 UTC 2024 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="asns-20240331.xsd#DocumentAndEntityInformation" roleURI="http://www.actelis.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:role="http://www.actelis.com/role/DocumentAndEntityInformation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="asns-20240331.xsd#asns_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrb8xOYtPeNESS0HWLdfr4iJuQUueersOTwI6y96qaPrzmCkI4XgUC/a77N1YAxjVvK6XJ/t3hMDB9h6bm/YJY9/Cfosp6rHHihBSXm+WUhImH/p8fDoXIJWn1l7wWOxO4Wgm0T7u8NTQ1gd173I/ypiFG+doEzErmrChuCObD9h86POgBnnZkYGL3zimT/q1v6ZVyD8nLwXJH0vPMLRHuMy1Yp7IMKI4Nc=] CSR-->
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm140076947772752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Actelis
Networks, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001141284<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( ,*#_5@'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #"@_U8E:@._^\    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9)1
M2\,P$,>_BN2]O30=BJ'+BV-/"H(#Q;>0W+9@TX;DI-VW-ZU;A^@'\#%W__SN
M=W"-"=+T$9]C'S"2PW0S^K9+TH0U.Q(%"9#,$;U.94YTN;GOH]>4G_$ 09L/
M?4 0G-^"1])6DX8)6(2%R%1CC301-?7QC+=FP8?/V,XP:P!;]-A1@JJL@*EI
M8CB-;0-7P 0CC#Y]%] NQ+GZ)W;N #LGQ^26U# ,Y5#/N;Q#!6]/CR_SNH7K
M$NG.8/Z5G*13P#6[3'ZM'S:[+5."BU7![PIQOQ-<UESRU?OD^L/O*NQ[Z_;N
M'QM?!%4#O^Y"?0%02P,$%     @ PH/]6)E<G",0!@  G"<  !,   !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ PH/]6#JJHN=  0  / (
M  \   !X;"]W;W)K8F]O:RYX;6R-45UKPS ,_"O&/V!)RU98:09CW4=A;&4=
M?7=BI1&UK6"K[=9?/R4AK+"7/<DZB=/=>7&BN"^)]NK+NY *W3"W\RQ+50/>
MI"MJ(<BDIN@-2QMW66HC&)L: /8NF^;Y+/,&@[Y;C%SKF%TVQ% Q4A"P [8(
MI_0[[UIUQ(0E.N3O0O=O!UIY#.CQ#+;0N5:IH=,+13Q38.,V523G"CT9!EN(
MC-4?>-.)_#1EZA$VY8<1(86>Y4)88TS<;_3\1C0>09:'[L#TA(XA+@W#<Z1#
MBV'7T8B+[,)&G\-8AQ#G\3\Q4EUC!4NJ#AX"#SE&<)W D!ILDU;!>"CTN*+N
M@U6/@24DM0H#E>QV3N7TR@ZN6>1>9!CG*(.XLH/P4:V%&@/8-SF0!)?DJG54
M7>EYIM<WDUM)Z.#<@V#OX96,'<V/'W?W U!+ P04    " #"@_U8)!Z;HJT
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M2P$"% ,4    " #"@_U8!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( ,*#_5B5J [_[P   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M ,*#_5B97)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ PH/]6$/'DVG\ @  80D  !@
M     ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M ,*#_5B?H!OPL0(  .(,   -              "  4 +  !X;"]S='EL97,N
M>&UL4$L! A0#%     @ PH/]6)>*NQS     $P(   L              ( !
M' X  %]R96QS+RYR96QS4$L! A0#%     @ PH/]6#JJHN=  0  / (   \
M             ( !!0\  'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( ,*#
M_5@D'INBK0   /@!   :              "  7(0  !X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( ,*#_5AED'F2&0$  ,\#   3
M          "  5<1  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D
*/@(  *$2      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>9</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ea0210134-s1_actelis.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.actelis.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>asns-20240331.xsd</File>
    <File>asns-20240331_def.xml</File>
    <File>asns-20240331_lab.xml</File>
    <File>asns-20240331_pre.xml</File>
    <File doctype="S-1" isOnlyDei="true" original="ea0210134-s1_actelis.htm">ea0210134-s1_actelis.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image_001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="9">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0210134-s1_actelis.htm": {
   "nsprefix": "asns",
   "nsuri": "http://www.actelis.com/20240331",
   "dts": {
    "schema": {
     "local": [
      "asns-20240331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/sic/2024/sic-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "asns-20240331_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "asns-20240331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "asns-20240331_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ea0210134-s1_actelis.htm"
     ]
    }
   },
   "keyStandard": 9,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 12,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 9
   },
   "report": {
    "R1": {
     "role": "http://www.actelis.com/role/DocumentAndEntityInformation",
     "longName": "000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0210134-s1_actelis.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0210134-s1_actelis.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.actelis.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "asns_DocumentAndEntityInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.actelis.com/20240331",
     "localname": "DocumentAndEntityInformationAbstract",
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.actelis.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.actelis.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.actelis.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.actelis.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.actelis.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.actelis.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Ex Transition Period",
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.actelis.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.actelis.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.actelis.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.actelis.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001013762-24-002108-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001013762-24-002108-xbrl.zip
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M(N3UK7M;S\UPV(3OYJCP^C*MG)'ZN%.[?.$C]JG@M)W7J[%KWQ#3L-\'Y6_
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M![#0[CO0:V#=;F#N+8O^4!8]2<:AS)P\>;G94K;W^G0J(N<C,&+@N:?97^I
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M ]@_$-/Z^]=U/6"M48S.C;&OCA%AKC"W09J T;ZC\@'^Z^3D]/3=N[OS*$P
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M2Q,X90Y?=Z04PGP]NB3]"C!O0KHMD"=2%#^L7DM%!2I?!0&!"&1]^#+\RY_
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M&88 J^@K6+D(_#TV...^* U8&:FX$OS.,+))FGDU;U&%IG%4@$VEB,(%R'#
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MJM2NA(:O )6XI_HE,!DP7\B0,(Q!%AA6C">3&,P%M,.!%8D.F@@807@!S=A
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MJ $+*?R<GA[&+X?1&#I5E/DK5M%Y=_=V]VW?'Z'/\R=GL0ZV>3-?P1$5.+X
MF=F+0C^:,E"%GINMY7/,2<8#SN!&+ NWB=ZR3P[%IQ@57*=8ZX0/"KB,87&3
M@*E.I63",)R3U2*? 1H4=#LKQR-W&,CFO\&KFRM-E!+@^+ "&X[3XJ#IK5Y'
M.3O:5TLK@RAU?AKV5*P-> IVH>/^QIN!J3IBF4U76909H>RE PX69S*G@D]2
M9 R,.'MF[;F4X<*0=T58<$D]H*0?&@9LGE>5X%A3W/RPH3GCO<U4NP*L:1E0
MDI/%&G"+1@AXKK!)LBSQZ5</TVXRCT%;\B&I.S7>J'23J.)(D='9N$$8&B\R
MN.%5PMD$SG@7;VM5?D/Z0)--6ZTPP%,LOX8P/&%Y]4UL7:EGJ+U0X03J'7"S
M[^AT5AW2I]FK## .!R<5V'K2MBJL%-Q0UH#*KYI5=RP]M>F%AH.J]1=<;,%.
M ^90\@DPRQ@6'H7%J$0LL['NZ0A7JQOGHR[_6$UF];=I:YRW2LN&&>>G.HN3
MB'R'R:6LEWSB.W(B*8]#X:U.P"I2A5BJ=T3I$43)%H&,C=D&ZG.>*MN#19HK
MPQ]$5FKL*E2$2%I6=*:0;V;*;*TDFO*8)&$>AT^8%P3A(U*?#WQ"W7 ,@N5+
M2696+TT*%&(ZQU4.1=3GSH7E(!JX%F[1--=> C*\PQ&2B*$7[FB$MV50P+4$
M$PD*M!(G5AQ4R;LB3<EU03K-2%II0)XR'O$G^R8R5S4(X"B92G1PL*<7[B?\
ML$AKV5#4''K^# SU O-@LUSM1:FXH;*%:%YS:36D>O50MF>HI%$&RDU3?X-(
MPVPFD!U/K8O14DV]BI='S5BWD\)FCF:JO#>^@8C$JQUN)73-C,>HDDCLC.03
M;=6BV1LX3(%EV===%=;;S9MOEN42O<ZP7P.\'.,R0$\D8N(6*#@B1"S(Q,]3
MI J9^6;Q-E;UJY@P+7F-);]9:5A,C'+XXZSQ* 6@S<6L,E04_6[W4"^"TN4J
M._=>3%BKZ<N >\F$7-^+Q3EI637Z*0Y!I>(AZ3B;1J7'P$EPHZ BP'EF%$)H
M.,LJX=K \BF,.6Q6!>L)FZK.8.5,5[B<NFGA]WR;ZY2J'R@MY515%S.MQWZN
MU7Q8E@+E&APX^&O'?0?S@W.(ZE_=.-HSDJOR'1>3[52JMCY-?\+G61"6+4)Q
MJGHQ*=>"A)]>3=2E<)VR NTN+;& N34KDZ C:8-H>1KJE%]LV*Q&EE[<(F)]
M6GG[!A0Z,77:M$2=2HH,+&F,"N=$X%;15H1ECFINL456OI'<=%KG-.^<]S[.
M_T198')&R.4U16$!.\6)-W8+*B[]57]&0OEP3(UJ[U8Z3)$8KOAV#2<B$"MY
MUH@(A:64A[Y"!P_TE5=&QIA;*^Y62UBI4@9_F*@QZH^C^D\%\]4"!RUV^."J
M+<5LI-06WZ1T_UD +Z%]QD/3$0^QDQ5BXO;%#9Q;"RIR7.0Z+;*\/!INH(9+
MAT4]V[J4,JG- V5IXRX3CUK23E<%-KVA+#<WKW@X Z"MI5YZ&L=H)%XK(Y'G
M]".+J=M"W;OU96GN.5E5K6I%O,8W41834(0?<Z4IV3$@- 0E>*ON@KB2]\?9
MYUI,.[6R*Y]U+5(K,KL[IFZ[P*!OV/N2D%=Z,DHFWESR;#J,<Z,7!IQ-/J71
M1)0E#@.ER,"CCA%4VT#WJA9K*E41KC+YI8HR81>.<;\NTY /)&^:Y67-1E-]
MVV>)<P@ET2YRPOQ3[K5,Y4%0DCZ!C>2E)46X=/ '.)&H*Y3W0OEV[4<MXGX:
MRCB(2"\H8DRM\U$CTU,@6(R)# =#%<G*R'&4P\0)6K^&O@&$C),,WFHM LR\
MISJ6:@)*S9TWDKZC\$UL7U&,0.KHLAJ5!D*8<I'& R-HM +E^RK_0;^"^SG,
MALA;'*VE J<&SO>LXJ"[E :!4:&5]O(]3D.:-%@DA8^0C!Z7XF*'&P.8:!6Z
M$%M:)4"B6G9DE1O-&ME&XR5)Y^B)Z*),*OS1-@Q6X>HP!G.Z5=-[B[DVI82;
MN;XLG1]E$A8L--6<J>B.5^L:^!OL!AS9#R+]@G[AE/ [*0S-S8!,T1,["8YY
M750"O<J/UTCE>[M[SUY9SI.Y1,Q0\<\DD^.A^R$!D7,3YO]9@I+9':HDLLU0
M=O"*@$8LSXA=.%0E;X:^LRP5,G+/PQNZ(J^+FU"X;T0:R9M;D^I\D]3#%D+H
MCM-83_3TY\MGT'\K-[Z:U#TOQ_[GRJ#?:S/HU_6X;](\WI>PA0ZZ.;4GS7//
MX"(>Q66Y+VH#MA.CBB\1QAEHS<"!K6F\"7.J8U@ITQ>U.!'&,P!4[*O#6[UT
MM2KML&2#/N4(Q)*ZS 1BA":5\1<6480>29@46CYC#$'DJC=A+17G!'V-*,UR
MC%PDLQ7CJMZ.S51,N2"B&(.].3343%I?Q7LXDH4*2B6.A2Y<D=E:O,HV+9<
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MW0PIBAO*K%DPU@'E2%^SH5Q1KBE'H1^F<*91*?5E1F(-Y2:*8Y%Z2F#A=[1
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M;J<J-*-0?K0^>UVR^)7JEZB%^3J4BO98?:*EZ9/<8GVB&77]<:JD6BF3A?N
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MB46$4'Y^0MBLE"GOMI0IZ<6RH9\<]PS]&V*9WY>/C!4)Y#0Y>S@V+O5@C@(
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M&[1A,<95U*K6%+;&-5?#%]<6AT@Q !:;%[578=7N= !V/D<7J>PIZ31IE/9
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MPV04K&BLW'KJ9M3Q+=-BGB6F&"3;&*:3 .+MH5YULY$I;0,I?AL1!L72"Y0
MV[SW<//4U.K@8FE6Y6,6.3(A'.9'[OO<'L!+Q2B+\/>\:F<))W0E^N,WNEW
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M!G4,7?AWBNCC]UAA%ZM8F<$.Y9H(M[-'T<8\8)*C>=;E*!L*6ML)+W%49RK
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M<:K#*,/_JPKVAF)F6[_H%[_YIU\0_ ]02P,$%     @ PH/]6(_=-ZZ) @
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M%Z#70JQ/2[JAWGSG)\,6?^K/ZG"D?Z]I ?U,)V"C@KF@PZ[&'66WDF_.>G]
M1T.["0F9?G4HE/:YKH59#P;NV2+[]/,BV=]1]U=L_[FGF?''PK=GF.JC/@CB
M2BP5\BQ:I5_T*,CWB98%V&<&]M5H?2XWPZ39-Y2G5%XHHPH-\[2E34ZU"<%Z
M:FZ&+?;+%:QBR)$I<AQU<)?6FFFLL(V68]DSLE.QD;3;]DN(DKC!Z%[/P8WF
MJD'=!NSGP<@X#3'(,2<(1(C#$T"+7[@04#,Z"8^NFXVC'8));JE/<"19ZNP2
MW+%Y\(%#$69#]SDCH!<F&HP7:I>OE2'#T6<F[H&YW@SUC+A)3%V$CM>;C.MB
M)K"EM8-/\):$;'!J)X<'LQ)*@RI+G%<,:$PV,VVJZ6U-^Z5=+]:%<=;YBL%P
M1=T&E@%X_7>)$/ P?_"NA1,23,6B<!?S'!XI]BUCW\]H0(U460.X4U@-!JP3
MG4&2X0B"HY,.<!F6&IA)AR5QCB39EB4K]M]CG7V!P>W8CEY"G( ;QU_V.NVD
MWIJOY?0P4G,[FB.RQJY','7^+4G.IP6+B6VW418_PY1LP-H#%FZ>NO<)A-/&
MO )-3&?B3TNPLWL6#.%"8&'4#1E'Y7N$1_',:)9R^:YZ]C2=(U1*@Z7-G(F?
M 6',1D SF7A\^F-]610)>/P#J+QG$8<*K>=3<5Q*+4<AU')TYE&-=MI+9]4(
MG_PSORT4QP6\<.>1VVV_2'2,?Z2P=.',QN3%DAG,DUL/K S44GKR_/=&/!7[
MO>9B^^?.9UOZLRY5HQ76$F_6#KBI%GRK*4N*Q'1GEQ+G0^)H,#GLR5$C=(H#
M&L\N52\@$_96 =E9(9N5VEFMC:LS9R;+=0WT'TL&2PA<5S.\_9A12J/<P^W!
M:H#9C#K:A3K1^$6Q1!]A!C0;ZUO]R=EMX"S05Q#^DM*&]D>4V(9DF(Q<,YHR
M."_Y<_&.&#^[!8\F3/MQ!%>!I.]T]+HS VX#QE$E="?-1!\W;\,5,=^]TJ1N
M&HGMP=A_*D:0VZI2'?YIR:G-)RBI]U7%^=_ SG#T88$D\$R/.UR<$D1I*%A#
MECE247')60.]>&5L3)Q*<U67]*M[D4#T/3W+@4KUN>#<OD;PU4J@#*OJ2!"?
M+ZN AR5GTF(97A&V6$EI1F>2 O%IL;7LUF3/7:=AG!CVU.[%[*=8/= O!&^.
MP??$7B(\FJQ^>=GST2;K4HUU>OBKU49O[SE;7]G79QGH;G0\%R)%-,-0SH-H
M(+Z3> 1,I1/$+UP9;3>F%BF@MP6[\R3GAAIOR"K>)FZC:NTY*"_AOS4<BA[=
M#ZU9F2A-+D5(I-0ZB"4_LX^LGJISD0X<*;]P/%+[4K6+4Z7]DZ-/RLUR$X[F
MWGK@F?Q@HD-R8VBCCHGF0N)G-RL9*L7EG$ED?5:Q+]6K*.49D9'=25#V\5Y5
MO.9Z60T=Q1%B-)?=1/8&"%O\+&]-/_SFC3OKS95?MGKL>I8.N\Y2&.O/SFLW
MW0W *)'EII!\6&>@89.N4D039HMR(1<F"CIWHHKB7@8C3 OW=<HQ9S(3%".W
MHA7#$$7KLH/2/J%?>0U*%2J/[]I/6JRT% /4?V=?8Q.24]:-WNT?;]87PYCW
MJ2@Q-#-"]%13!F^M4E>5Z.$O!H/O/+ZQ%3VNK^:O%8*^2='B?,7[?F/,<R$L
M\=G%_I[69'+#RC"G3\48Z*V+/RA7'ZSJ84(T'BL=YD)>)X1=;JEFLMS965[A
MT<S[A_T7GNG\*>V#ENLG$^6N69@7^X-S[[(*Q,,^.W<VE/<\L7G0YF%B:,P,
MQZRM-*U.5"5V48&-YHN3*@:UVI(75V]I?5;Y[/& UJC8K-5L85:95)6Z5&5=
MRKQ_#_W@@9W6A:BF2&+;^7>EO\(YHAJ\XEG&=YER(>A-4&,S!19 FLZE<2$I
M%OX,GB"D_>X>DIWY$9O=0Y#'!$]O(857S!)V.GI6VA:*@_R4ND0^&MU44/08
M^IC>9<S:9VWPI?/T08AJ51?]1=_M.,0H10KF!YL96"3%?P?O,L*9-\!Y8*Q+
MMG4RUGLHG14&S/;B%(&OBB5EGPLC$V:(M16>7WJCL3\&@D)_Z;8>K#F*4!58
MNF)[6H:M'M]_)5Q(FO$XU)S_$378=(WA?M!'23GQR=/1AWXIW0BR[\HI^Y$G
MOI[85XR"@*_VD@E/ A3..6 &[0T0F[*EZA3_;\\X*7C@'S1X7'/M+!7ZI9]Y
MF'V?)UGIO;'X7J0(UA2,!$+1>V= .3(7,NW&,>P@9?_=.'IM4K=V"MZ6Y'AN
M9X:_RDXM1_O]M1B3(W7+0K/VX\W"N97+3+GHWW=G#-'^>PL,8M)ZO:(?UOPU
M!YL\?2B3G(5BO2$M$K@0  Z;+>I#-IFN!3'PY]G9I$"*.$M^TM*")<C(0$H:
M#<5S3G< ZES(75^P@/INT(9<CWD^91VB@13MJ3@;$QGVLOS[%UISDD=AY-^Z
ML.D C[> ?C=%$"3T[KP8M5"GPH0"/2GI%LZU\I(S0_;#6\J6WQ&3VW'+1ZTT
M<WPK9^86+ELJ)X2]A92(_4%MW6$_/@W/M-18! =$:+\5_=_Z^*<-&:J<*.WU
M2#+-##=._13NG]GIWRYCI6 AZ]HS;<(O@)!)3%*26"^U/]G9G:C5(QR#:^[Q
MT9ZDLAHPQ@^N:$^5"QF]=NDY)Z]]N6GYS<7JK+Q3'XG:3=\&C,8ROVEGN2(<
M<<ZLF^U@S.Y)K,84S@(W09)N5]ZU9*D!X\$[V2GM?KCL*J2W_8&F$0MSZJ[!
M3M8[FN-?U<>+GRWG>*^89KP:F4TIS?^;XT4TXY'<++11K)LBC@S"-T#7@FCZ
M6;#I5H.S_@PK9@KC'@AU&#]'/AC;D@[\[BE$I.@_;WIPP\BD;6*CX$7*@,*U
ME)>E>![8 <\Z4 ?1BP>U*]<]:$@E),J,F+E[F@6;; X18(:!%T,UTVV'+531
MX3Q=:S1IM&FX-H4[PV@Z\:JV+CC<1FU2_/(LB.N=@H_='YC$=ZGP]$$2OBF9
M);-[F5%1OPB7PJ"H<EW0),^LHE+P%UTL?1T=Z?Z-(5M^@)3<S>.4ST5J<CR5
MFB)E#T63"N-JS6U'K[RI-XW.-IZ3_8FWQNAMB>V8@FK H[72>\N, $EJQQ,N
M9#++K/CXT?Z^#J,G.E=>RS^!,34\CMG_JMS^IZ'<W2$?Z?$](5A?P)*AG_X+
M_)AX^7,%/_^Q-Q;[W;[?*SUFOB 3[/J"YXTN#%XB'^MPK9A,WI"[AU]D;L[8
M7)@XC#R$(T/YF^M$=7H/M> D>5R/%%JYZ94*R5L_WBRB0\XWL+V_\?-I?M^!
MLIQ+GIA+K?I;/+;>.\=C["?X10(4<()*_T *-L_.HYF7P56:4LI:$Y0?>[5M
MM*![07]"H9:>[@"@R9F6OD_G5WXW..BX!\ZLF8F68X[^U*6WO8U()!W$F>*[
M<LR2'@/,WT[L$E@(@T9*;8FZ-3>+0=/ZNW]@]:AG0E>$$3D17RS.4[,E43M)
M.7K?/M9V='Q;R(D)V;\=5^[^NPG? ^N#)I D\0'(]!(8J,=P_8L$(,F;"1R#
M"98R77G/UX<=(Q8.U($_>L='3]-GO&4#W9;ZF/.L=^D>5]I:PP^][-^5/9&@
MJG@SP?> NOPYB0Q?^5YU^3X)YPP_&>E2&1D9_VLUM8!C:]1L=,B[EHW9=Z'K
M%,1M]*O*W=&I)=/_OYVF#K$4\[B0?0F,NO5J -]+J$>O*]&*-J59,>PB[,D*
M%%ZL/>R5=U%'- W1Q1>)?MHO2L+?6EJ]R$#TU%X(T;=].UX14Q>9+;8RXSA!
M'XRI6#$-Q]'Q78&D;]+(UM_L(DUR'=NPPRF;\5?=UGU>.E1A7X?P-S9W3Z.%
MN)"5VE$4:W:5K09;?#_TQY R:\[Y[-5-VJF.*(1PIHP%1T<_TS9<4VY0\S>N
M"[^I<1MI'S5XT:4K(^C4_EV^CB;,[&:_QB^.9,_T_]L2B$=Q(PL2WJZTG55$
M%,Z @4RP5&9%@N$O,04>H\=+^C:^]QI@3Q%Z\E4TB3%Z_QBL[#R4*_A]\WEH
M1\1L]CJ)3/AY?)4+8>Z;P&\E\<"_'YT!_>E&/,:CV_.,5DY96S$$_UJ?)5'-
M?,YK2O:L*X  6>P> ;!7ECH+M-ZU%&Y-W,Y.,1--!U;))<*%7IL*F<%3?T]N
M=Z!Z309>8?H]QP62MFTWC$,03A/Z(WKYIT,E33-1S'3G\0BV*IPXT8Q:/6/H
M,*:[$:GLX#(>ZMLPML6V_"CWMIU(;'^+J5W77=>C/: M+=%LJ??D%SR\5:U]
M.7@8X%?)2L8O/B<P!=E%7,A6(UT&UXCO6L W39$I=PC /YE*G2312$?XV59V
MF:4QKPBP<37+DG8A41;[0J@$<<R Q[#*QE&5A0'R;\5])7E5^P[/?[$+N^I^
M/ES[C4 &ONLL;!&HFU9EWF+P1'(_\RSH^Q(WY:,+;'_[_+B*=99 MNJ$[2L=
MK]6,BWMDI!P2,8@B^QBV)+SZ-F'4<;3'NOW:M=?C&[XYQY-I93Q>B_V^_G6G
M\VTK^Q'>_XW17W/+!C#RV\W'#C?WO[9 2%])[-1C%TPM=7Y#@>\A%G<O)AX$
M7?J%GA5!ZM?VQYQ)-F8/L61Y(#JA3]3E#/H(@<])K=_CO6BP;);2<[#?.KZ+
M(IJ=SA$_+TNJZ'KIX6E%%\;+S*(4OS4W16N%6-95!M6?C51S@8>$JE[SA.R&
M,RUX@XUR(0$4Z&HL(A%V@Y?K'C*%+ZO4S'. H4^]WLZ%2%M(51IJ/_=!^2B1
MQK:@\D%,M/EU_%HO0SK_IHY=^A,$TP'PHR=WZ\^H4NL2B2=88F F53\-?[ ]
MX$IA=E([:K'#A^(^W.P0Q?_)?>/P5>94U&=LT;H9T_RV#?PMHIG8W/HFDX;\
M*<,#52*O?4!@BZ4PX,+M<V=0_5R($+R7DH"8Z25F/F?Y@X<+DS.Q6L8;Y;%&
M;,4A<NS?;LY@:5=L5FVD7D?S0S-.SO[B\)BP?<7YU3%A1Y]Q(59BH"E/]2/H
M:% #O_9W&Z+O#)YLR IE/VT.4:6UDNOX'.I6JJGH1"EEO?5VV.)M.=M[RS?T
M6#9^Y3ZA#&;=7BW+JCKIL6OY<6)B0:$0BU*.T!$>64# Q[O6N%&B,F_*@9Q^
M%7W\ 1^0U'<3:P)V,9(O=.R>H2$ORZFH X3$9GEYNX!*$.V0[HR7#LYWT7B&
MCT-KI/JJ'35/(C"+J.@UO=T3+$-0>)$P/4$4Q_#W4<18<O)O')!0C,U?C&LS
ME-1*88UF^AG$;G#?EB--+VK+(?(V]N3Q#Y(3ASQ[I!U8-IP)"@#/GG5E6H//
M:,K17@""#),,9!*/$2?;#1ETZCRQL<9S53\L[LQV/LFRD3J\0TIBV45<GD?.
M^*0[O->WH"L-\*7%G/;6YPA-\:)3!EV#1#/EUDWI34F?CZ!1?@PQVY'(N#='
M4_;98BGB/QC!X0?&^8A+,>5]_*<UC=GZ:<#GF V[^[[MEK3+A:<.:2A?#7MU
MJNW+#3>_HO%*:- CVDGY &U&GG:H.U9#M-D,SN?X64OK0EDY\\M<H<P)>?A:
MS749:I6+:]V <]O$:O/FI:ICEB$R=,5;=JZ(ALGO.RH@JD=%";B>7 $&=%M"
MAUDZU$&5^1"C8OZ>PDM9R<^#\E_:>868VX]=::EOO&NG?K7UGM$'S5 [8XX=
M!8B KS\@-5>R9*)I??'/@M-?L,ZP"[:*#9F10$SK&SG96\$^,OFKKF#JBW.,
M]\S1CJGL[<S8]]YGR4Q%GR=9/V.$4%MC- 3KT#[>RN@"Z(1V>%WKNF8%W69D
M\]536PN!Q:A"A][$T<^GZBL??/XM)CM^N%HBO@\%]C#0:9%#2F 1V=* 8?G,
MI(Z&E$7-#*6V6[V<>XTJ=O"::A;<=G3C+&8=G"J8<IVSN[/_SP$(!,)*SGPC
M=7KQQ@4QL1(_@[4+AB>?(10.7 F+/)DG<VSB8L<KC7+[B^O:$Y?_((SM'WRM
MTII9'J"MG!^K,KLUT37=W(ASW$!A#< X&CH=*<'B!QJ[HAQ?@"0:/*/=<!$N
M_.6XS<PV%R*[:A(KFL-_0N#:+22RL^$]SIU^?.U<E2J[\U\R$&))LE/QUV%W
M"8V_,+.='$&@CO=[HJ40&'Y]A@M):SISY!#H]5?#6+/P]+<.8NLOG@8Y)]QQ
M;L<OOW")%C27?PO%"L!?02=SU!B5ZWQ4-JIG)CH%#:6.WP(_? <F2FHC7TPC
M9Z6;1M33'!6U]$/4S8K)COO(<.F< <5V]%N='2>@;NW7K@OK\H3DIC6HRJ#0
M5.HQ]DI]@$VF<8<UM57NZN^VO-(ATP617Y\NWIJ3#-\^)$AU%#W^ 14P39"^
M@HG>!Y?S$K$O.7HJ&BG^XMR32D]#,OUU4]#H]RIMY_",LN_[1V^._UF;-2M!
MNA@%7GGIIWW*.N2<B_VAT6"M%ZX/RR.*@HQ19>OA6U,<T54&?*U@]P*GGR!L
M$0G4T9$]%!46BEV,TU6K?8;1=&IEZ$XA18E'W5LR:77-JX47HV-OG/S1ME%$
M31]!'7^:H1)7^NW/G20NQ$Q]Q;*TTJ>9O>3(TV:A;"+N--:2D7RGG/VX_=(S
M#TQKCR+QX2]PR G8C'>;\:K6LOP0\:%NI>660NWQ24%:ZM&8?W*._7W], )H
MIJ,%,,E42@8+L2@FM]SX8T$7@*4V;Q[ E-J^[9X+\CD"3-9&/U\UBZ"#U^O'
M;X2&E*T3#;-.(G7Z#YU^ $R:"R9^,%PYO:WX*&9 PC/OAK*',_E<=7H&L=RE
M7+Z[W%1A[/+/O/'<T+YI$]^,3UJ(?$,!BT/+$\Z5"N=J5%T>/B]7T+RD\;68
MKJ.67PB=)+"4JGG5$0)N[YJPY,"N7650O5T]W!]-FP0_+%939-QYFK+02'&[
M.2F>KFQJ]]IAP$'UFK&2LJ8[_E0[*63BN/MU$W]D)4^D-^,!)[&95IK FA;#
MX2PCNG=3'/Z,93W5KDP50?44&D5Y"B2_,G*T\DS:O#3F/[8U$'CM;6-[$ME*
M32[:5/OL]Z@]V=]:.8(A#*4NI"@>C9YN6*5%-=8$XH582 ;T;S",8>HZ7'%/
M^=Q0U\*9=^D]T84)(6&')K\&R44S8WL$2[5)5^;*Y76RMTQXU/Z=UXT.6QX\
MRTM6 ;MB&WZ7>(BA4<NPH4;E4(<R/*/J:E;-6E.-4>M*U(T.OQI,7[_#6.TE
M/5F'3<'CK]_?][A?XO*Q4ML*JW%4M.;F"O1=Q*K6>%-%1\W5N5H=<_.%07--
M_XYL<Z7\ &,P7CB]/ NEE?!ZHMK7YVB9G,7QEV.9BF'V847.N=]S$4M>:OA\
M.^>.LY<WKIR";-^(#:?$CV?EL3?Q74TP #ZD,(=[_X#7D*3 &SO)J9S38 \Y
M"@80?(J4Y \#-O>V@]K-44^7"Q-7>[6_M)#\:N=7&%]2<6,1^0,&L"]T3XY
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MF#R6NW?@-0RP08*:G>\U.0J_SH6:75G963B@>D]4],!BEHT,B\ #*PD&V!-
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M2P$"% ,4    " #"@_U80]$'9%\$  #H#   $0              @ $
M87-N<RTR,#(T,#,S,2YX<V102P$"% ,4    " #"@_U8_?WSN*X$   0%P
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M,3,T+7,Q7V%C=&5L:7,N:'1M4$L! A0#%     @ PH/]6"]!K=U0!@  )S@
M !T              ( !%JL  &5A,#(Q,#$S-# Q97@M9F5E7V%C=&5L:7,N
M:'1M4$L! A0#%     @ PH/]6(_=-ZZ) @  Z L  !T              ( !
MH;$  &5A,#(Q,#$S-# Q97@R,RTQ7V%C=&5L:7,N:'1M4$L! A0#%     @
MPH/]6(PM<^7A#   OSP  !P              ( !9;0  &5A,#(Q,#$S-# Q
M97@U+3%?86-T96QI<RYH=&U02P$"% ,4    " #"@_U84#R:]Z0X  #@.@
M#0              @ & P0  :6UA9V5?,# Q+FIP9U!+!08     "0 ) &D"
(  !/^@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>ea0210134-s1_actelis_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="asns-20240331.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141284</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <dei:DocumentType contextRef="c0" id="ixv-3642">S-1</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-39">Actelis Networks, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0" id="ixv-53">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFilerCategory contextRef="c0" id="ixv-180">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c0" id="ixv-187">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c0" id="ixv-197">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c0" id="ixv-3643">false</dei:EntityExTransitionPeriod>
    <dei:AmendmentFlag contextRef="c0" id="ixv-3646">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-3647">0001141284</dei:EntityCentralIndexKey>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
